CDC7
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
Log-Odds: S Sites / S Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| O00311 | S216 | EPSD|PSP | CDC7 CDC7L1 | DFGLAQGTHDTKIELLKFVQsEAQQERCSQNKSHIITGNKI |
| O00311 | S239 | EPSD|PSP | CDC7 CDC7L1 | QQERCSQNKSHIITGNKIPLsGPVPKELDQQSTTKASVKRP |
| O00311 | S277 | EPSD|PSP | CDC7 CDC7L1 | KRPYTNAQIQIKQGKDGKEGsVGLsVQRsVFGERNFNIHss |
| O00311 | S285 | EPSD|PSP | CDC7 CDC7L1 | IQIKQGKDGKEGsVGLsVQRsVFGERNFNIHssISHEsPAV |
| O00311 | S296 | EPSD|PSP | CDC7 CDC7L1 | GsVGLsVQRsVFGERNFNIHssISHEsPAVKLMKQSKTVDV |
| O00311 | S297 | EPSD|PSP | CDC7 CDC7L1 | sVGLsVQRsVFGERNFNIHssISHEsPAVKLMKQSKTVDVL |
| O00311 | S318 | EPSD|PSP | CDC7 CDC7L1 | ISHEsPAVKLMKQSKTVDVLsRKLATKKKAISTKVMNSAVM |
| O75475 | S206 | SIGNOR|EPSD|PSP | PSIP1 DFS70 LEDGF PSIP2 | TEVKIPKPRGRPKMVKQPCPsEsDIItEEDKSKKKGQEEKQ |
| P06748 | S137 | EPSD|PSP | NPM1 NPM | VAVEEDAEsEDEEEEDVKLLsIsGKRsAPGGGsKVPQKKVK |
| P06748 | T199 | EPSD|PSP | NPM1 NPM | DDFDDEEAEEKAPVKKsIRDtPAKNAQKSNQNGKDsKPsst |
| P11388 | S1213 | EPSD|PSP | TOP2A TOP2 | LPGKGGKAKGKKTQMAEVLPsPRGQRVIPRITIEMKAEAEK |
| P11388 | S1525 | EPSD|PSP | TOP2A TOP2 | AVAPRAKSVRAKKPIKYLEEsDEDDLF______________ |
| P19338 | T121 | EPSD|PSP | NCL | AKAVTtPGKKGAtPGKALVAtPGKKGAAIPAKGAKNGKNAK |
| P19338 | T76 | EPSD|PSP | NCL | AAATsAKKVVVsPtKKVAVAtPAKKAAVtPGKKAAAtPAKK |
| P49736 | S108 | GPS6|SIGNOR|EPSD|PSP | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | DAYEAEGLALDDEDVEELtAsQREAAERAMRQRDREAGRGL |
| P49736 | S13 | SIGNOR | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | ________MAEssEsFtMAssPAQRRRGNDPLtssPGRssR |
| P49736 | S139 | SIGNOR|EPSD|PSP | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | QRDREAGRGLGRMRRGLLyDsDEEDEERPARKRRQVERAtE |
| P49736 | S220 | EPSD|PSP | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | KNFLRTHVDsHGHNVFKERIsDMCKENREsLVVNyEDLAAR |
| P49736 | S27 | SIGNOR|EPSD|PSP | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | sFtMAssPAQRRRGNDPLtssPGRssRRtDALtssPGRDLP |
| P49736 | S31 | EPSD|PSP | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | AssPAQRRRGNDPLtssPGRssRRtDALtssPGRDLPPFED |
| P49736 | S4 | EPSD|PSP | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | _________________MAEssEsFtMAssPAQRRRGNDPL |
| P49736 | S40 | GPS6|SIGNOR|EPSD|PSP | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | GNDPLtssPGRssRRtDALtssPGRDLPPFEDEsEGLLGtE |
| P49736 | S41 | SIGNOR|EPSD|PSP | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | NDPLtssPGRssRRtDALtssPGRDLPPFEDEsEGLLGtEG |
| P49736 | S5 | SIGNOR|EPSD|PSP | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | ________________MAEssEsFtMAssPAQRRRGNDPLt |
| P49736 | S53 | GPS6|SIGNOR|EPSD|PSP | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | RRtDALtssPGRDLPPFEDEsEGLLGtEGPLEEEEDGEELI |
| P49736 | S7 | EPSD|PSP | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | ______________MAEssEsFtMAssPAQRRRGNDPLtss |
| P55081 | S116 | EPSD|PSP | MFAP1 | DVEERLARHRKIVEPEVVGEsDsEVEGDAWRMEREDssEEE |
| Q8TEA8 | S179 | SIGNOR|PSP | DTD1 C20orf88 DUEB HARS2 | QLSKLEKQQQRKEKTRAKGPsEssKERNtPRKEDRsAssGA |
| Q8TEA8 | S181 | SIGNOR|PSP | DTD1 C20orf88 DUEB HARS2 | SKLEKQQQRKEKTRAKGPsEssKERNtPRKEDRsAssGAEG |
| Q8TEA8 | S182 | SIGNOR|PSP | DTD1 C20orf88 DUEB HARS2 | KLEKQQQRKEKTRAKGPsEssKERNtPRKEDRsAssGAEGD |
| Q8TEA8 | S194 | SIGNOR|PSP | DTD1 C20orf88 DUEB HARS2 | RAKGPsEssKERNtPRKEDRsAssGAEGDVssEREP_____ |
| Q8TEA8 | S196 | SIGNOR|PSP | DTD1 C20orf88 DUEB HARS2 | KGPsEssKERNtPRKEDRsAssGAEGDVssEREP_______ |
| Q8TEA8 | S197 | SIGNOR|PSP | DTD1 C20orf88 DUEB HARS2 | GPsEssKERNtPRKEDRsAssGAEGDVssEREP________ |
| Q8TEA8 | S204 | SIGNOR|PSP | DTD1 C20orf88 DUEB HARS2 | ERNtPRKEDRsAssGAEGDVssEREP_______________ |
| Q8TEA8 | S205 | SIGNOR|PSP | DTD1 C20orf88 DUEB HARS2 | RNtPRKEDRsAssGAEGDVssEREP________________ |
| Q8TEA8 | T187 | SIGNOR|PSP | DTD1 C20orf88 DUEB HARS2 | QQRKEKTRAKGPsEssKERNtPRKEDRsAssGAEGDVssER |
| Q96GD4 | T236 | PSP | AURKB AIK2 AIM1 AIRK2 ARK2 STK1 STK12 STK5 | IADFGWSVHAPsLRRKtMCGtLDYLPPEMIEGRMHNEKVDL |
| Q9HAW4 | S110 | EPSD|PSP | CLSPN | ENLYAGKNTKIKRIYKTVADsDESYMEKSLyQENLEAQVKP |
| Q9HAW4 | S1129 | EPSD|PSP | CLSPN | DDKRQLRLYQERYLADGDLHsDGPGRMRKFRWKNIDDAsQM |
| Q9HAW4 | S1147 | EPSD|PSP | CLSPN | LHsDGPGRMRKFRWKNIDDAsQMDLFHRDsDDDQtEEQLDE |
| Q9HAW4 | S260 | EPSD|PSP | CLSPN | VKNKVKKHKKKEPSLESGVHsFEEGsELSKGTTRKERKAAR |
| Q9HAW4 | S265 | EPSD|PSP | CLSPN | KKHKKKEPSLESGVHsFEEGsELSKGTTRKERKAARLSKEA |
| Q9HAW4 | S67 | EPSD|PSP | CLSPN | DEEIFVSKKLKNRKVLQDsDsEtEDTNAsPEKttyDsAEEE |
| Q9HAW4 | S704 | EPSD|PSP | CLSPN | SEEIETKDEKEMDKENNDGssEIGKAVGFLSVPKSLssDst |
| Q9HAW4 | S721 | EPSD|PSP | CLSPN | DGssEIGKAVGFLSVPKSLssDstLLLFKDSSSKMGYFPTE |
| Q9HAW4 | S744 | EPSD|PSP | CLSPN | tLLLFKDSSSKMGYFPTEEKsETDENSGKQPSKLDEDDsCs |
| Q9NS91 | S434 | SIGNOR|EPSD|PSP | RAD18 RNF73 | EPDREEDSSSCIDIQEVLSSsESDSCNSSSSDIIRDLLEEE |
| Q9UBU7 | S312 | EPSD|PSP | DBF4 ASK DBF4A ZDBF1 | KKGYCECCLQKYEDLEtHLLsEQHRNFAQSNQYQVVDDIVS |
| Q9UBU7 | T273 | EPSD|PSP | DBF4 ASK DBF4A ZDBF1 | FDVDKPssMQKQTQVKLRIQtDGDKYGGtsIQLQLKEKKKK |
| Q9UBU7 | T281 | EPSD|PSP | DBF4 ASK DBF4A ZDBF1 | MQKQTQVKLRIQtDGDKYGGtsIQLQLKEKKKKGYCECCLQ |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Chromatin organization | R-HSA-4839726 | 8.405043e-11 | 10.075 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.514221e-09 | 8.820 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 3.081822e-09 | 8.511 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.379052e-07 | 6.860 | 1 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 4.152501e-07 | 6.382 | 1 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 9.433120e-07 | 6.025 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 8.900887e-07 | 6.051 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.318882e-06 | 5.880 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.959574e-06 | 5.529 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.959574e-06 | 5.529 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.410608e-06 | 5.467 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 4.607970e-06 | 5.336 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 4.662774e-06 | 5.331 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.026498e-05 | 4.989 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.406082e-05 | 4.852 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.116697e-05 | 4.674 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.852992e-05 | 4.545 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.178900e-05 | 4.498 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 4.311940e-05 | 4.365 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 4.311940e-05 | 4.365 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 4.567598e-05 | 4.340 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 6.147082e-05 | 4.211 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 6.147082e-05 | 4.211 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 7.682747e-05 | 4.114 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 7.428682e-05 | 4.129 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 8.564565e-05 | 4.067 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 9.465029e-05 | 4.024 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.017793e-04 | 3.992 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.010279e-04 | 3.996 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.103341e-04 | 3.957 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.316203e-04 | 3.881 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.752695e-04 | 3.756 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.699645e-04 | 3.770 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.789171e-04 | 3.747 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.789171e-04 | 3.747 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.246742e-04 | 3.648 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.695275e-04 | 3.569 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 3.226279e-04 | 3.491 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 3.237860e-04 | 3.490 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 3.639145e-04 | 3.439 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.638950e-04 | 3.439 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.638950e-04 | 3.439 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 4.360252e-04 | 3.360 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 4.360252e-04 | 3.360 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 6.686786e-04 | 3.175 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 6.632203e-04 | 3.178 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 6.686786e-04 | 3.175 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 6.794940e-04 | 3.168 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 7.312339e-04 | 3.136 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 7.873283e-04 | 3.104 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 8.547090e-04 | 3.068 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.221884e-03 | 2.913 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.196419e-03 | 2.922 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 1.302536e-03 | 2.885 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.281046e-03 | 2.892 | 1 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.310270e-03 | 2.883 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.338421e-03 | 2.873 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.747690e-03 | 2.758 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.841764e-03 | 2.735 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.867070e-03 | 2.729 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.036056e-03 | 2.691 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.036056e-03 | 2.691 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 2.082972e-03 | 2.681 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.243556e-03 | 2.649 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.495714e-03 | 2.603 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.683557e-03 | 2.571 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 2.983289e-03 | 2.525 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 3.142213e-03 | 2.503 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 3.177407e-03 | 2.498 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 3.289031e-03 | 2.483 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.471417e-03 | 2.459 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.458314e-03 | 2.461 | 1 | 1 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 3.537051e-03 | 2.451 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 3.698280e-03 | 2.432 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.889026e-03 | 2.410 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 4.385480e-03 | 2.358 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 4.397588e-03 | 2.357 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 4.604948e-03 | 2.337 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 5.109479e-03 | 2.292 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 5.401689e-03 | 2.267 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 5.609672e-03 | 2.251 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 5.650048e-03 | 2.248 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 5.650048e-03 | 2.248 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 5.650048e-03 | 2.248 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 5.650048e-03 | 2.248 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 5.745848e-03 | 2.241 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 6.183894e-03 | 2.209 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 6.926738e-03 | 2.159 | 1 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 7.087630e-03 | 2.149 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 7.182831e-03 | 2.144 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 7.237572e-03 | 2.140 | 1 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 7.642268e-03 | 2.117 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 8.116962e-03 | 2.091 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 7.766652e-03 | 2.110 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 8.210875e-03 | 2.086 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 8.957634e-03 | 2.048 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 9.311779e-03 | 2.031 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 9.786460e-03 | 2.009 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 9.884524e-03 | 2.005 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.158956e-02 | 1.936 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.249345e-02 | 1.903 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.333046e-02 | 1.875 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.396154e-02 | 1.855 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 1.491395e-02 | 1.826 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.502041e-02 | 1.823 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.559383e-02 | 1.807 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.621647e-02 | 1.790 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.621647e-02 | 1.790 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.662234e-02 | 1.779 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.570136e-02 | 1.804 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.764456e-02 | 1.753 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 1.764456e-02 | 1.753 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.821104e-02 | 1.740 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.921275e-02 | 1.716 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.994646e-02 | 1.700 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.312850e-02 | 1.636 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.312850e-02 | 1.636 | 0 | 0 |
| SDK interactions | R-HSA-373756 | 2.312850e-02 | 1.636 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.312850e-02 | 1.636 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.312850e-02 | 1.636 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.312850e-02 | 1.636 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 2.312850e-02 | 1.636 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.184557e-02 | 1.661 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.236128e-02 | 1.651 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.379177e-02 | 1.624 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.154319e-02 | 1.667 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.240869e-02 | 1.650 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 2.170275e-02 | 1.663 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.272170e-02 | 1.644 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.529619e-02 | 1.597 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.599610e-02 | 1.585 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.614345e-02 | 1.583 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.723052e-02 | 1.565 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.046049e-02 | 1.516 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 3.111252e-02 | 1.507 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 3.228449e-02 | 1.491 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 3.228449e-02 | 1.491 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 3.253398e-02 | 1.488 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 3.371977e-02 | 1.472 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 3.530954e-02 | 1.452 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.388075e-02 | 1.470 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 3.478667e-02 | 1.459 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 3.658851e-02 | 1.437 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 4.081666e-02 | 1.389 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 4.081666e-02 | 1.389 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 4.081666e-02 | 1.389 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 4.066991e-02 | 1.391 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 4.066991e-02 | 1.391 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 4.066991e-02 | 1.391 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 4.066991e-02 | 1.391 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 3.794479e-02 | 1.421 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 3.794479e-02 | 1.421 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 3.794479e-02 | 1.421 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 4.066991e-02 | 1.391 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 3.794479e-02 | 1.421 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 4.081666e-02 | 1.389 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 4.066707e-02 | 1.391 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 4.141537e-02 | 1.383 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 4.159574e-02 | 1.381 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 4.233121e-02 | 1.373 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 4.297249e-02 | 1.367 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 4.427782e-02 | 1.354 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 4.549539e-02 | 1.342 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 4.925633e-02 | 1.308 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 4.925633e-02 | 1.308 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.025828e-02 | 1.299 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 5.025828e-02 | 1.299 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 4.566484e-02 | 1.340 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 4.714818e-02 | 1.327 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 5.136641e-02 | 1.289 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 4.862169e-02 | 1.313 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 4.573995e-02 | 1.340 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 4.841097e-02 | 1.315 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.925633e-02 | 1.308 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 4.925633e-02 | 1.308 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 4.825776e-02 | 1.316 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 4.793220e-02 | 1.319 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 5.025828e-02 | 1.299 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 5.259051e-02 | 1.279 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 5.293115e-02 | 1.276 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 5.293115e-02 | 1.276 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 5.293115e-02 | 1.276 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 5.293115e-02 | 1.276 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 5.293115e-02 | 1.276 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 5.293115e-02 | 1.276 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 5.338417e-02 | 1.273 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 5.429413e-02 | 1.265 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 5.429413e-02 | 1.265 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 5.489834e-02 | 1.260 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 5.569300e-02 | 1.254 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 5.662960e-02 | 1.247 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 6.106213e-02 | 1.214 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 6.106213e-02 | 1.214 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 6.106213e-02 | 1.214 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 6.395414e-02 | 1.194 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 6.395414e-02 | 1.194 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 6.395414e-02 | 1.194 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 6.667367e-02 | 1.176 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 6.240681e-02 | 1.205 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 6.106213e-02 | 1.214 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 5.855582e-02 | 1.232 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 6.667367e-02 | 1.176 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 6.059856e-02 | 1.218 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 6.386930e-02 | 1.195 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 6.386930e-02 | 1.195 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 6.678403e-02 | 1.175 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 6.714872e-02 | 1.173 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 6.738212e-02 | 1.171 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 6.738212e-02 | 1.171 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 6.740750e-02 | 1.171 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 6.740750e-02 | 1.171 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 6.767401e-02 | 1.170 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 6.767401e-02 | 1.170 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 6.767401e-02 | 1.170 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 6.767401e-02 | 1.170 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 6.767401e-02 | 1.170 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 6.767401e-02 | 1.170 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 6.977073e-02 | 1.156 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 6.977073e-02 | 1.156 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 7.078618e-02 | 1.150 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 7.116481e-02 | 1.148 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 7.961949e-02 | 1.099 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 7.307747e-02 | 1.136 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 7.307747e-02 | 1.136 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 8.303061e-02 | 1.081 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 7.836934e-02 | 1.106 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 7.631279e-02 | 1.117 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 8.222465e-02 | 1.085 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 7.432019e-02 | 1.129 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 7.432019e-02 | 1.129 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 8.222465e-02 | 1.085 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 7.530467e-02 | 1.123 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 8.303061e-02 | 1.081 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 8.222465e-02 | 1.085 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 8.171167e-02 | 1.088 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 7.493129e-02 | 1.125 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 7.744554e-02 | 1.111 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 7.307747e-02 | 1.136 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 7.589634e-02 | 1.120 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 8.571415e-02 | 1.067 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 8.628471e-02 | 1.064 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 8.628471e-02 | 1.064 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 8.628471e-02 | 1.064 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 8.628471e-02 | 1.064 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 8.874093e-02 | 1.052 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 9.055116e-02 | 1.043 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 9.095689e-02 | 1.041 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 9.130486e-02 | 1.040 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 9.240780e-02 | 1.034 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 9.369328e-02 | 1.028 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 9.372135e-02 | 1.028 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 9.372135e-02 | 1.028 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.464105e-02 | 1.024 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 9.464105e-02 | 1.024 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 9.478952e-02 | 1.023 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 9.564353e-02 | 1.019 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 9.583603e-02 | 1.018 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 9.584389e-02 | 1.018 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 1.096415e-01 | 0.960 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.096415e-01 | 0.960 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.096415e-01 | 0.960 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.096415e-01 | 0.960 | 0 | 0 |
| Signaling by FGFR1 amplification mutants | R-HSA-1839120 | 1.155464e-01 | 0.937 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 1.155464e-01 | 0.937 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.155464e-01 | 0.937 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.121702e-01 | 0.950 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.121702e-01 | 0.950 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.121702e-01 | 0.950 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 1.121702e-01 | 0.950 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.121702e-01 | 0.950 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 9.946798e-02 | 1.002 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.111921e-01 | 0.954 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.041669e-01 | 0.982 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 1.113987e-01 | 0.953 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 9.946798e-02 | 1.002 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 9.629179e-02 | 1.016 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.120450e-01 | 0.951 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.100697e-01 | 0.958 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 9.946798e-02 | 1.002 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 9.778240e-02 | 1.010 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 1.155464e-01 | 0.937 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 9.801230e-02 | 1.009 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 9.875626e-02 | 1.005 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.801230e-02 | 1.009 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 1.121702e-01 | 0.950 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.159946e-01 | 0.936 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 1.181167e-01 | 0.928 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.181167e-01 | 0.928 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.181167e-01 | 0.928 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.181167e-01 | 0.928 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.193908e-01 | 0.923 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.203933e-01 | 0.919 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.206045e-01 | 0.919 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.213525e-01 | 0.916 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.221570e-01 | 0.913 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.223662e-01 | 0.912 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.227967e-01 | 0.911 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.072674e-01 | 0.683 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.072674e-01 | 0.683 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.072674e-01 | 0.683 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.072674e-01 | 0.683 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 2.072674e-01 | 0.683 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.546615e-01 | 0.811 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.546615e-01 | 0.811 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.941939e-01 | 0.531 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 2.941939e-01 | 0.531 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.941939e-01 | 0.531 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 2.941939e-01 | 0.531 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.941939e-01 | 0.531 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 1.958347e-01 | 0.708 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 1.958347e-01 | 0.708 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.958347e-01 | 0.708 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 1.958347e-01 | 0.708 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 1.958347e-01 | 0.708 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 1.958347e-01 | 0.708 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.958347e-01 | 0.708 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.376593e-01 | 0.861 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.376593e-01 | 0.861 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.648862e-01 | 0.783 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 1.648862e-01 | 0.783 | 0 | 0 |
| Signaling by MST1 | R-HSA-8852405 | 2.381451e-01 | 0.623 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 2.381451e-01 | 0.623 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 3.715931e-01 | 0.430 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 3.715931e-01 | 0.430 | 0 | 0 |
| Defective ALG9 causes CDG-1l | R-HSA-4720454 | 3.715931e-01 | 0.430 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 3.715931e-01 | 0.430 | 0 | 0 |
| Defective F8 cleavage by thrombin | R-HSA-9672391 | 3.715931e-01 | 0.430 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 3.715931e-01 | 0.430 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.715931e-01 | 0.430 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 3.715931e-01 | 0.430 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 3.715931e-01 | 0.430 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 3.715931e-01 | 0.430 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 3.715931e-01 | 0.430 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 3.715931e-01 | 0.430 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 3.715931e-01 | 0.430 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 3.715931e-01 | 0.430 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.715931e-01 | 0.430 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 3.715931e-01 | 0.430 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 3.715931e-01 | 0.430 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 3.715931e-01 | 0.430 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.715931e-01 | 0.430 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 3.715931e-01 | 0.430 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 1.381488e-01 | 0.860 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.935312e-01 | 0.713 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 1.935312e-01 | 0.713 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 2.808488e-01 | 0.552 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 2.808488e-01 | 0.552 | 0 | 0 |
| PKA activation | R-HSA-163615 | 1.326572e-01 | 0.877 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 2.232834e-01 | 0.651 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 2.232834e-01 | 0.651 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 2.232834e-01 | 0.651 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 2.232834e-01 | 0.651 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 2.232834e-01 | 0.651 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 2.232834e-01 | 0.651 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 1.501739e-01 | 0.823 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.400701e-01 | 0.854 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 2.538473e-01 | 0.595 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 2.538473e-01 | 0.595 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.538473e-01 | 0.595 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 3.233514e-01 | 0.490 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 3.233514e-01 | 0.490 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.233514e-01 | 0.490 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 3.233514e-01 | 0.490 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 4.405087e-01 | 0.356 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 4.405087e-01 | 0.356 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 4.405087e-01 | 0.356 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.405087e-01 | 0.356 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 4.405087e-01 | 0.356 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.405087e-01 | 0.356 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.405087e-01 | 0.356 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.300951e-01 | 0.886 | 1 | 1 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 1.300951e-01 | 0.886 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 2.849467e-01 | 0.545 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.849467e-01 | 0.545 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.849467e-01 | 0.545 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.849467e-01 | 0.545 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.849467e-01 | 0.545 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.849467e-01 | 0.545 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.849467e-01 | 0.545 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 1.324119e-01 | 0.878 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.447857e-01 | 0.839 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.890460e-01 | 0.723 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 2.541347e-01 | 0.595 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 3.651837e-01 | 0.437 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 3.651837e-01 | 0.437 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 3.163278e-01 | 0.500 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 2.794580e-01 | 0.554 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 1.299407e-01 | 0.886 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.816295e-01 | 0.741 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 2.714134e-01 | 0.566 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 4.059820e-01 | 0.391 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 5.018701e-01 | 0.299 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 5.018701e-01 | 0.299 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 5.018701e-01 | 0.299 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 5.018701e-01 | 0.299 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.143280e-01 | 0.669 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.143280e-01 | 0.669 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 2.143280e-01 | 0.669 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 2.143280e-01 | 0.669 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 2.143280e-01 | 0.669 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.735607e-01 | 0.761 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.899677e-01 | 0.721 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 3.310723e-01 | 0.480 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.025764e-01 | 0.693 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.799348e-01 | 0.745 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 3.790402e-01 | 0.421 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 3.790402e-01 | 0.421 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 3.790402e-01 | 0.421 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 3.790402e-01 | 0.421 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 3.790402e-01 | 0.421 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 2.155289e-01 | 0.666 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 3.158320e-01 | 0.501 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.909101e-01 | 0.719 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 2.288047e-01 | 0.641 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 4.454701e-01 | 0.351 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 4.454701e-01 | 0.351 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.454701e-01 | 0.351 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.137462e-01 | 0.670 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 2.423825e-01 | 0.615 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 3.383872e-01 | 0.471 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 3.383872e-01 | 0.471 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.383872e-01 | 0.471 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.383872e-01 | 0.471 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 2.664499e-01 | 0.574 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 3.219590e-01 | 0.492 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 2.178158e-01 | 0.662 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.939040e-01 | 0.532 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.939040e-01 | 0.532 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.939040e-01 | 0.532 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.939040e-01 | 0.532 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 2.816647e-01 | 0.550 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 2.816647e-01 | 0.550 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 2.816647e-01 | 0.550 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 2.211472e-01 | 0.655 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.610594e-01 | 0.442 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.610594e-01 | 0.442 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 3.421703e-01 | 0.466 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 3.106443e-01 | 0.508 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 3.127611e-01 | 0.505 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 3.625014e-01 | 0.441 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.837679e-01 | 0.416 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 3.837679e-01 | 0.416 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 4.089887e-01 | 0.388 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 4.089887e-01 | 0.388 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 4.834447e-01 | 0.316 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 5.565050e-01 | 0.255 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 5.565050e-01 | 0.255 | 0 | 0 |
| FGFR1c and Klotho ligand binding and activation | R-HSA-190374 | 5.565050e-01 | 0.255 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 5.565050e-01 | 0.255 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 5.565050e-01 | 0.255 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 5.565050e-01 | 0.255 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 2.467257e-01 | 0.608 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.661562e-01 | 0.575 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 2.882958e-01 | 0.540 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 3.285831e-01 | 0.483 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 3.285831e-01 | 0.483 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 3.446563e-01 | 0.463 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 3.606251e-01 | 0.443 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 3.606251e-01 | 0.443 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 4.032904e-01 | 0.394 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 4.702620e-01 | 0.328 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 3.417160e-01 | 0.466 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 3.964562e-01 | 0.402 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 5.197631e-01 | 0.284 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 5.197631e-01 | 0.284 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 5.197631e-01 | 0.284 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 5.197631e-01 | 0.284 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 5.197631e-01 | 0.284 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 5.197631e-01 | 0.284 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 4.137901e-01 | 0.383 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 4.137901e-01 | 0.383 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 4.993463e-01 | 0.302 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 4.993463e-01 | 0.302 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 4.639823e-01 | 0.333 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 4.416910e-01 | 0.355 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 4.416910e-01 | 0.355 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 5.275961e-01 | 0.278 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 5.275961e-01 | 0.278 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 5.275961e-01 | 0.278 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 6.051504e-01 | 0.218 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 6.051504e-01 | 0.218 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 6.051504e-01 | 0.218 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 6.051504e-01 | 0.218 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 6.051504e-01 | 0.218 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 6.051504e-01 | 0.218 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 6.051504e-01 | 0.218 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 6.051504e-01 | 0.218 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 6.051504e-01 | 0.218 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 6.051504e-01 | 0.218 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 6.051504e-01 | 0.218 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 5.168382e-01 | 0.287 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 4.898918e-01 | 0.310 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 4.444673e-01 | 0.352 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 4.963308e-01 | 0.304 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 5.549357e-01 | 0.256 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 5.549357e-01 | 0.256 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 5.549357e-01 | 0.256 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 5.549357e-01 | 0.256 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 5.549357e-01 | 0.256 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 5.565695e-01 | 0.254 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 5.565695e-01 | 0.254 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 5.565695e-01 | 0.254 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 5.565695e-01 | 0.254 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 5.870976e-01 | 0.231 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 5.870976e-01 | 0.231 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 5.870976e-01 | 0.231 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 5.870976e-01 | 0.231 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 5.870976e-01 | 0.231 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 5.382445e-01 | 0.269 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 5.792433e-01 | 0.237 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 5.969981e-01 | 0.224 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 5.971190e-01 | 0.224 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 6.012382e-01 | 0.221 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.066636e-01 | 0.217 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 6.180403e-01 | 0.209 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 6.180403e-01 | 0.209 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 6.255635e-01 | 0.204 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 6.114669e-01 | 0.214 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.366670e-01 | 0.626 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 2.021850e-01 | 0.694 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 4.696701e-01 | 0.328 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 3.646030e-01 | 0.438 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 4.355694e-01 | 0.361 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 4.355694e-01 | 0.361 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 1.878583e-01 | 0.726 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 3.646030e-01 | 0.438 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 3.646030e-01 | 0.438 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.438811e-01 | 0.842 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.502521e-01 | 0.602 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 4.639823e-01 | 0.333 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 5.327925e-01 | 0.273 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 3.281610e-01 | 0.484 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 2.525976e-01 | 0.598 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 2.541347e-01 | 0.595 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 3.310723e-01 | 0.480 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.897227e-01 | 0.722 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 1.873071e-01 | 0.727 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.878583e-01 | 0.726 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.556888e-01 | 0.808 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 3.163278e-01 | 0.500 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 4.639823e-01 | 0.333 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 5.251097e-01 | 0.280 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.326572e-01 | 0.877 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.072522e-01 | 0.513 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.902846e-01 | 0.721 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 3.829266e-01 | 0.417 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 2.224887e-01 | 0.653 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 2.224887e-01 | 0.653 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 3.015924e-01 | 0.521 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 1.878583e-01 | 0.726 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 2.992556e-01 | 0.524 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 4.089887e-01 | 0.388 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 4.355694e-01 | 0.361 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 3.163278e-01 | 0.500 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.794580e-01 | 0.554 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.837679e-01 | 0.416 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 4.599701e-01 | 0.337 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 4.735074e-01 | 0.325 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 5.866426e-01 | 0.232 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.336884e-01 | 0.874 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.564446e-01 | 0.806 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.564446e-01 | 0.806 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 5.543318e-01 | 0.256 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.293218e-01 | 0.640 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 5.275961e-01 | 0.278 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 4.656913e-01 | 0.332 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 6.309772e-01 | 0.200 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 3.967850e-01 | 0.401 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 1.546615e-01 | 0.811 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.935312e-01 | 0.713 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 3.233514e-01 | 0.490 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.850832e-01 | 0.733 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 4.059820e-01 | 0.391 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 5.197631e-01 | 0.284 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 4.438845e-01 | 0.353 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 4.438845e-01 | 0.353 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 6.051504e-01 | 0.218 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 5.565695e-01 | 0.254 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 4.965035e-01 | 0.304 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 2.053240e-01 | 0.688 | 1 | 0 |
| Myogenesis | R-HSA-525793 | 1.720316e-01 | 0.764 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.106443e-01 | 0.508 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 2.051666e-01 | 0.688 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 2.051666e-01 | 0.688 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.939040e-01 | 0.532 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 3.106443e-01 | 0.508 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 5.278994e-01 | 0.277 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 5.791438e-01 | 0.237 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 2.019987e-01 | 0.695 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.253079e-01 | 0.647 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.301318e-01 | 0.638 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 3.510962e-01 | 0.455 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.648862e-01 | 0.783 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 2.381451e-01 | 0.623 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 1.577143e-01 | 0.802 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 4.059820e-01 | 0.391 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 5.018701e-01 | 0.299 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 3.837679e-01 | 0.416 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.768431e-01 | 0.558 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 4.289928e-01 | 0.368 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 4.438845e-01 | 0.353 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 5.543318e-01 | 0.256 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 5.168382e-01 | 0.287 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 6.225236e-01 | 0.206 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.403148e-01 | 0.619 | 1 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 3.964562e-01 | 0.402 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 3.287078e-01 | 0.483 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 5.093456e-01 | 0.293 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 6.309772e-01 | 0.200 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 5.936499e-01 | 0.226 | 1 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 4.508625e-01 | 0.346 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 5.813062e-01 | 0.236 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 5.093456e-01 | 0.293 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 5.881573e-01 | 0.231 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 5.881573e-01 | 0.231 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 1.724480e-01 | 0.763 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 5.420309e-01 | 0.266 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 4.099847e-01 | 0.387 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 5.012238e-01 | 0.300 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.477003e-01 | 0.831 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 3.791330e-01 | 0.421 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.475094e-01 | 0.831 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.326572e-01 | 0.877 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 4.099847e-01 | 0.387 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.604989e-01 | 0.795 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.078982e-01 | 0.682 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 6.114669e-01 | 0.214 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.726794e-01 | 0.763 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 1.958347e-01 | 0.708 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.818193e-01 | 0.740 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.577143e-01 | 0.802 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 3.651837e-01 | 0.437 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.724480e-01 | 0.763 | 1 | 1 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 3.163278e-01 | 0.500 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 4.059820e-01 | 0.391 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.692710e-01 | 0.771 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 2.021850e-01 | 0.694 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 4.404370e-01 | 0.356 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 3.625805e-01 | 0.441 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 4.993463e-01 | 0.302 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 4.953471e-01 | 0.305 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 5.168382e-01 | 0.287 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 4.290618e-01 | 0.367 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 5.984706e-01 | 0.223 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 4.075048e-01 | 0.390 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.381752e-01 | 0.860 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 5.549357e-01 | 0.256 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 2.025764e-01 | 0.693 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 3.139949e-01 | 0.503 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 2.042141e-01 | 0.690 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.255798e-01 | 0.647 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 2.664499e-01 | 0.574 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.294485e-01 | 0.888 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 2.479071e-01 | 0.606 | 1 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 5.543318e-01 | 0.256 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 3.790402e-01 | 0.421 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.514564e-01 | 0.600 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 1.311632e-01 | 0.882 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 3.403002e-01 | 0.468 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.381451e-01 | 0.623 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 5.018701e-01 | 0.299 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.767859e-01 | 0.424 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 6.051504e-01 | 0.218 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 5.791438e-01 | 0.237 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 6.309772e-01 | 0.200 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 6.257835e-01 | 0.204 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 2.279542e-01 | 0.642 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 5.174762e-01 | 0.286 | 1 | 0 |
| Mismatch Repair | R-HSA-5358508 | 2.794580e-01 | 0.554 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.599205e-01 | 0.796 | 1 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.491266e-01 | 0.260 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 3.878912e-01 | 0.411 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.291799e-01 | 0.640 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.536743e-01 | 0.813 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.655917e-01 | 0.781 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 3.300983e-01 | 0.481 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.735607e-01 | 0.761 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.735607e-01 | 0.761 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.735607e-01 | 0.761 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.735607e-01 | 0.761 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 4.404370e-01 | 0.356 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 5.791438e-01 | 0.237 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 1.890460e-01 | 0.723 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 5.792433e-01 | 0.237 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.565922e-01 | 0.805 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 5.536641e-01 | 0.257 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.292942e-01 | 0.888 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 2.541347e-01 | 0.595 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 4.404370e-01 | 0.356 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.538308e-01 | 0.595 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 2.084894e-01 | 0.681 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 5.543318e-01 | 0.256 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 5.549357e-01 | 0.256 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 6.066636e-01 | 0.217 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 5.057355e-01 | 0.296 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 4.993463e-01 | 0.302 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 4.661010e-01 | 0.332 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 5.303661e-01 | 0.275 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 3.625014e-01 | 0.441 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 3.945056e-01 | 0.404 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 3.287078e-01 | 0.483 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 1.994873e-01 | 0.700 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 4.073510e-01 | 0.390 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 3.572945e-01 | 0.447 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.941939e-01 | 0.531 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 1.958347e-01 | 0.708 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.648862e-01 | 0.783 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 3.715931e-01 | 0.430 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.715931e-01 | 0.430 | 0 | 0 |
| Defective factor XII causes hereditary angioedema | R-HSA-9657688 | 3.715931e-01 | 0.430 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.381488e-01 | 0.860 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 1.935312e-01 | 0.713 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 2.538473e-01 | 0.595 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 1.556888e-01 | 0.808 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.447857e-01 | 0.839 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.447857e-01 | 0.839 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.794580e-01 | 0.554 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 3.477608e-01 | 0.459 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 4.059820e-01 | 0.391 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 5.018701e-01 | 0.299 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 5.018701e-01 | 0.299 | 0 | 0 |
| GABA synthesis | R-HSA-888568 | 5.018701e-01 | 0.299 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 3.219590e-01 | 0.492 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.805682e-01 | 0.743 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 2.971117e-01 | 0.527 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 5.565050e-01 | 0.255 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 3.439262e-01 | 0.464 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 4.702620e-01 | 0.328 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 3.964562e-01 | 0.402 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 5.197631e-01 | 0.284 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 4.993463e-01 | 0.302 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 4.202434e-01 | 0.376 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 5.093456e-01 | 0.293 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 6.114136e-01 | 0.214 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 6.247715e-01 | 0.204 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 4.361554e-01 | 0.360 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 2.687746e-01 | 0.571 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 2.366670e-01 | 0.626 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.155289e-01 | 0.666 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 2.238801e-01 | 0.650 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.546605e-01 | 0.811 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.360633e-01 | 0.866 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 4.444391e-01 | 0.352 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 5.035541e-01 | 0.298 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 6.180403e-01 | 0.209 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.556888e-01 | 0.808 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 2.562398e-01 | 0.591 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.818193e-01 | 0.740 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.289928e-01 | 0.368 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 3.404858e-01 | 0.468 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 5.607726e-01 | 0.251 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 3.091506e-01 | 0.510 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 4.059820e-01 | 0.391 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 2.821398e-01 | 0.550 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 4.661010e-01 | 0.332 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 4.825843e-01 | 0.316 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.366670e-01 | 0.626 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 4.454701e-01 | 0.351 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.732301e-01 | 0.563 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 3.812310e-01 | 0.419 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.674914e-01 | 0.435 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 3.635177e-01 | 0.439 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 5.275961e-01 | 0.278 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 4.735074e-01 | 0.325 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 3.999111e-01 | 0.398 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 5.457274e-01 | 0.263 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.366670e-01 | 0.626 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 3.310723e-01 | 0.480 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 6.225236e-01 | 0.206 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 6.309772e-01 | 0.200 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 5.327925e-01 | 0.273 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 5.966244e-01 | 0.224 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.053240e-01 | 0.688 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 4.092420e-01 | 0.388 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 2.467257e-01 | 0.608 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 2.332875e-01 | 0.632 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 1.648862e-01 | 0.783 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 3.163278e-01 | 0.500 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.326047e-01 | 0.877 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 5.543318e-01 | 0.256 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 5.093082e-01 | 0.293 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 5.966244e-01 | 0.224 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 2.773901e-01 | 0.557 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 5.792433e-01 | 0.237 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 5.769198e-01 | 0.239 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 3.766468e-01 | 0.424 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 3.019282e-01 | 0.520 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 3.625805e-01 | 0.441 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.448242e-01 | 0.462 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 6.118958e-01 | 0.213 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 1.326572e-01 | 0.877 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.435857e-01 | 0.843 | 0 | 0 |
| Kinesins | R-HSA-983189 | 3.930010e-01 | 0.406 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 1.878583e-01 | 0.726 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 4.639823e-01 | 0.333 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 4.523539e-01 | 0.345 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 6.309772e-01 | 0.200 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.096813e-01 | 0.678 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.935312e-01 | 0.713 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 4.405087e-01 | 0.356 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 4.405087e-01 | 0.356 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 2.849467e-01 | 0.545 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 3.570984e-01 | 0.447 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 4.454701e-01 | 0.351 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 4.454701e-01 | 0.351 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 4.099847e-01 | 0.387 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.831076e-01 | 0.417 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 2.971117e-01 | 0.527 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 4.702620e-01 | 0.328 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 3.572945e-01 | 0.447 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 5.197631e-01 | 0.284 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 4.438845e-01 | 0.353 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 4.371930e-01 | 0.359 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 4.735074e-01 | 0.325 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 4.735074e-01 | 0.325 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.051504e-01 | 0.218 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 5.332549e-01 | 0.273 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 6.180403e-01 | 0.209 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.005963e-01 | 0.301 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 1.501739e-01 | 0.823 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 2.182460e-01 | 0.661 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.735607e-01 | 0.761 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 3.147272e-01 | 0.502 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 5.629980e-01 | 0.249 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 5.971190e-01 | 0.224 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 4.963308e-01 | 0.304 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 4.089887e-01 | 0.388 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 5.580873e-01 | 0.253 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 5.275961e-01 | 0.278 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 5.229474e-01 | 0.282 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 2.808488e-01 | 0.552 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 2.808488e-01 | 0.552 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 3.790402e-01 | 0.421 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 6.309772e-01 | 0.200 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 2.415052e-01 | 0.617 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 4.775781e-01 | 0.321 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 3.862220e-01 | 0.413 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 3.051493e-01 | 0.515 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 2.664499e-01 | 0.574 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.982018e-01 | 0.525 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 3.715931e-01 | 0.430 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 3.233514e-01 | 0.490 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 4.405087e-01 | 0.356 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 3.651837e-01 | 0.437 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 4.059820e-01 | 0.391 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 5.018701e-01 | 0.299 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 4.099847e-01 | 0.387 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 5.565050e-01 | 0.255 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 3.561231e-01 | 0.448 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 6.051504e-01 | 0.218 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 6.051504e-01 | 0.218 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 5.870976e-01 | 0.231 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 5.585952e-01 | 0.253 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 4.589531e-01 | 0.338 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.818193e-01 | 0.740 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 3.233514e-01 | 0.490 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 4.405087e-01 | 0.356 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 4.454701e-01 | 0.351 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 6.051504e-01 | 0.218 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 6.180403e-01 | 0.209 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.794580e-01 | 0.554 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 6.113040e-01 | 0.214 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 5.332549e-01 | 0.273 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 5.276832e-01 | 0.278 | 0 | 0 |
| Regulation of gene expression in early pancreatic precursor cells | R-HSA-210747 | 4.834447e-01 | 0.316 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 3.618546e-01 | 0.441 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 6.051504e-01 | 0.218 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 3.999111e-01 | 0.398 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 6.051504e-01 | 0.218 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 3.439262e-01 | 0.464 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 5.116509e-01 | 0.291 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 3.285831e-01 | 0.483 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 3.477608e-01 | 0.459 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 5.275961e-01 | 0.278 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.454701e-01 | 0.351 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 6.098182e-01 | 0.215 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 6.012382e-01 | 0.221 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 6.317954e-01 | 0.199 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 6.358632e-01 | 0.197 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 6.362344e-01 | 0.196 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 6.362344e-01 | 0.196 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 6.362344e-01 | 0.196 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 6.362344e-01 | 0.196 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 6.379652e-01 | 0.195 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 6.394363e-01 | 0.194 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 6.430759e-01 | 0.192 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 6.461850e-01 | 0.190 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 6.463596e-01 | 0.190 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 6.471654e-01 | 0.189 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 6.471654e-01 | 0.189 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 6.471654e-01 | 0.189 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 6.471654e-01 | 0.189 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 6.471654e-01 | 0.189 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 6.471654e-01 | 0.189 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 6.471654e-01 | 0.189 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 6.471654e-01 | 0.189 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 6.471654e-01 | 0.189 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 6.471654e-01 | 0.189 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 6.484611e-01 | 0.188 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 6.484626e-01 | 0.188 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 6.484626e-01 | 0.188 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 6.484626e-01 | 0.188 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 6.484626e-01 | 0.188 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 6.484626e-01 | 0.188 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 6.484626e-01 | 0.188 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 6.484626e-01 | 0.188 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 6.484626e-01 | 0.188 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 6.484626e-01 | 0.188 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 6.484626e-01 | 0.188 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 6.484626e-01 | 0.188 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 6.484626e-01 | 0.188 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 6.484626e-01 | 0.188 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 6.484626e-01 | 0.188 | 0 | 0 |
| CREB3 factors activate genes | R-HSA-8874211 | 6.484626e-01 | 0.188 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 6.484626e-01 | 0.188 | 0 | 0 |
| Defective factor VIII causes hemophilia A | R-HSA-9662001 | 6.484626e-01 | 0.188 | 0 | 0 |
| Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus | R-HSA-159763 | 6.484626e-01 | 0.188 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 6.542281e-01 | 0.184 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 6.542281e-01 | 0.184 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 6.542281e-01 | 0.184 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 6.542281e-01 | 0.184 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 6.542281e-01 | 0.184 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 6.542281e-01 | 0.184 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 6.542281e-01 | 0.184 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 6.542721e-01 | 0.184 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 6.542721e-01 | 0.184 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 6.542721e-01 | 0.184 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 6.559416e-01 | 0.183 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 6.564334e-01 | 0.183 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 6.586227e-01 | 0.181 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 6.586227e-01 | 0.181 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 6.595713e-01 | 0.181 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 6.595713e-01 | 0.181 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 6.598826e-01 | 0.181 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 6.624080e-01 | 0.179 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 6.628779e-01 | 0.179 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 6.628779e-01 | 0.179 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 6.663108e-01 | 0.176 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 6.663108e-01 | 0.176 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 6.717275e-01 | 0.173 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 6.717275e-01 | 0.173 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 6.744994e-01 | 0.171 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 6.744994e-01 | 0.171 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 6.744994e-01 | 0.171 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 6.744994e-01 | 0.171 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 6.744994e-01 | 0.171 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 6.760355e-01 | 0.170 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 6.764080e-01 | 0.170 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 6.803799e-01 | 0.167 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 6.803799e-01 | 0.167 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 6.803799e-01 | 0.167 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 6.819182e-01 | 0.166 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 6.819182e-01 | 0.166 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 6.819182e-01 | 0.166 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 6.826237e-01 | 0.166 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 6.870260e-01 | 0.163 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 6.870260e-01 | 0.163 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 6.870260e-01 | 0.163 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 6.870260e-01 | 0.163 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 6.870260e-01 | 0.163 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 6.870260e-01 | 0.163 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 6.870260e-01 | 0.163 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 6.870260e-01 | 0.163 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 6.870260e-01 | 0.163 | 0 | 0 |
| Cysteine formation from homocysteine | R-HSA-1614603 | 6.870260e-01 | 0.163 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 6.870260e-01 | 0.163 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.870260e-01 | 0.163 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.870260e-01 | 0.163 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 6.870260e-01 | 0.163 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 6.870260e-01 | 0.163 | 0 | 0 |
| Removal of aminoterminal propeptides from gamma-carboxylated proteins | R-HSA-159782 | 6.870260e-01 | 0.163 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 6.887119e-01 | 0.162 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 6.889564e-01 | 0.162 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 6.965451e-01 | 0.157 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 6.966930e-01 | 0.157 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 6.966930e-01 | 0.157 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 6.975173e-01 | 0.156 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 6.975173e-01 | 0.156 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 6.975173e-01 | 0.156 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 6.975173e-01 | 0.156 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 7.000003e-01 | 0.155 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 7.000848e-01 | 0.155 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 7.000848e-01 | 0.155 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 7.000848e-01 | 0.155 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 7.000848e-01 | 0.155 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 7.001909e-01 | 0.155 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 7.001909e-01 | 0.155 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 7.001909e-01 | 0.155 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 7.001909e-01 | 0.155 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 7.001909e-01 | 0.155 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 7.026649e-01 | 0.153 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 7.026649e-01 | 0.153 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 7.044491e-01 | 0.152 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 7.048545e-01 | 0.152 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 7.119485e-01 | 0.148 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 7.135606e-01 | 0.147 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 7.167199e-01 | 0.145 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 7.175644e-01 | 0.144 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 7.175644e-01 | 0.144 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.176947e-01 | 0.144 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 7.176947e-01 | 0.144 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 7.176947e-01 | 0.144 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 7.176947e-01 | 0.144 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 7.213610e-01 | 0.142 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 7.213610e-01 | 0.142 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 7.213610e-01 | 0.142 | 0 | 0 |
| ALKBH3 mediated reversal of alkylation damage | R-HSA-112126 | 7.213610e-01 | 0.142 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 7.213610e-01 | 0.142 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 7.213610e-01 | 0.142 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 7.213610e-01 | 0.142 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 7.213610e-01 | 0.142 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 7.213610e-01 | 0.142 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 7.213610e-01 | 0.142 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 7.213610e-01 | 0.142 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 7.213610e-01 | 0.142 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 7.213610e-01 | 0.142 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 7.213610e-01 | 0.142 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 7.213610e-01 | 0.142 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 7.213610e-01 | 0.142 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 7.213610e-01 | 0.142 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 7.213610e-01 | 0.142 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.219668e-01 | 0.141 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 7.239761e-01 | 0.140 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 7.239761e-01 | 0.140 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 7.239761e-01 | 0.140 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 7.239761e-01 | 0.140 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 7.341791e-01 | 0.134 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 7.344326e-01 | 0.134 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 7.344326e-01 | 0.134 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 7.344326e-01 | 0.134 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 7.344326e-01 | 0.134 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 7.344326e-01 | 0.134 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.354027e-01 | 0.133 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 7.355747e-01 | 0.133 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 7.355747e-01 | 0.133 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 7.355747e-01 | 0.133 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 7.365643e-01 | 0.133 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 7.365643e-01 | 0.133 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 7.446242e-01 | 0.128 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 7.452340e-01 | 0.128 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 7.462370e-01 | 0.127 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 7.462370e-01 | 0.127 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 7.462370e-01 | 0.127 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 7.462370e-01 | 0.127 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 7.462370e-01 | 0.127 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 7.462370e-01 | 0.127 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 7.462370e-01 | 0.127 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 7.462370e-01 | 0.127 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 7.462370e-01 | 0.127 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 7.500324e-01 | 0.125 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 7.500324e-01 | 0.125 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 7.504115e-01 | 0.125 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 7.504115e-01 | 0.125 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 7.514796e-01 | 0.124 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 7.516007e-01 | 0.124 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 7.519311e-01 | 0.124 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 7.519311e-01 | 0.124 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 7.519311e-01 | 0.124 | 0 | 0 |
| Enzymatic degradation of Dopamine by monoamine oxidase | R-HSA-379398 | 7.519311e-01 | 0.124 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 7.519311e-01 | 0.124 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.519311e-01 | 0.124 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 7.519311e-01 | 0.124 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 7.519311e-01 | 0.124 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 7.519311e-01 | 0.124 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 7.519311e-01 | 0.124 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 7.545374e-01 | 0.122 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 7.545374e-01 | 0.122 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.545374e-01 | 0.122 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 7.575635e-01 | 0.121 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 7.582385e-01 | 0.120 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 7.612440e-01 | 0.118 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 7.638939e-01 | 0.117 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 7.646661e-01 | 0.117 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 7.656415e-01 | 0.116 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 7.669378e-01 | 0.115 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 7.669378e-01 | 0.115 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 7.669378e-01 | 0.115 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 7.669378e-01 | 0.115 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 7.715088e-01 | 0.113 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 7.715088e-01 | 0.113 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 7.715088e-01 | 0.113 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.715088e-01 | 0.113 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 7.771655e-01 | 0.109 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 7.775210e-01 | 0.109 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 7.775210e-01 | 0.109 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 7.791488e-01 | 0.108 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 7.791488e-01 | 0.108 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 7.791488e-01 | 0.108 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 7.791488e-01 | 0.108 | 0 | 0 |
| Enzymatic degradation of dopamine by COMT | R-HSA-379397 | 7.791488e-01 | 0.108 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 7.791488e-01 | 0.108 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 7.791488e-01 | 0.108 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 7.791488e-01 | 0.108 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 7.791488e-01 | 0.108 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 7.791488e-01 | 0.108 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 7.791488e-01 | 0.108 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 7.791488e-01 | 0.108 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 7.791488e-01 | 0.108 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 7.791488e-01 | 0.108 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 7.801356e-01 | 0.108 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 7.820928e-01 | 0.107 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 7.820928e-01 | 0.107 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 7.859819e-01 | 0.105 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 7.861526e-01 | 0.104 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 7.861526e-01 | 0.104 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 7.861526e-01 | 0.104 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 7.861526e-01 | 0.104 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 7.861526e-01 | 0.104 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 7.875074e-01 | 0.104 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 7.875074e-01 | 0.104 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 7.875074e-01 | 0.104 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 7.875074e-01 | 0.104 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.883988e-01 | 0.103 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 7.898559e-01 | 0.102 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 7.914579e-01 | 0.102 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 7.937112e-01 | 0.100 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 7.937485e-01 | 0.100 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 7.939092e-01 | 0.100 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 7.939092e-01 | 0.100 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 7.939092e-01 | 0.100 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 7.939092e-01 | 0.100 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 7.939092e-01 | 0.100 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 7.939092e-01 | 0.100 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 7.939092e-01 | 0.100 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.025647e-01 | 0.096 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 8.025647e-01 | 0.096 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.025647e-01 | 0.096 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 8.033817e-01 | 0.095 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 8.033817e-01 | 0.095 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 8.033817e-01 | 0.095 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 8.033817e-01 | 0.095 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.033817e-01 | 0.095 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 8.033817e-01 | 0.095 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 8.033817e-01 | 0.095 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 8.033817e-01 | 0.095 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 8.033817e-01 | 0.095 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 8.033817e-01 | 0.095 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 8.039584e-01 | 0.095 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 8.039584e-01 | 0.095 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 8.039584e-01 | 0.095 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 8.040655e-01 | 0.095 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.069800e-01 | 0.093 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 8.069800e-01 | 0.093 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 8.099787e-01 | 0.092 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 8.105224e-01 | 0.091 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 8.112090e-01 | 0.091 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 8.112922e-01 | 0.091 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 8.112922e-01 | 0.091 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 8.112922e-01 | 0.091 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 8.112922e-01 | 0.091 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 8.135351e-01 | 0.090 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 8.167149e-01 | 0.088 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 8.190648e-01 | 0.087 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.193672e-01 | 0.087 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 8.204328e-01 | 0.086 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 8.204328e-01 | 0.086 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 8.204328e-01 | 0.086 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 8.208843e-01 | 0.086 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 8.209831e-01 | 0.086 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 8.226388e-01 | 0.085 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 8.226388e-01 | 0.085 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 8.249569e-01 | 0.084 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 8.249569e-01 | 0.084 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 8.249569e-01 | 0.084 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 8.249569e-01 | 0.084 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 8.249569e-01 | 0.084 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 8.249569e-01 | 0.084 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 8.249569e-01 | 0.084 | 0 | 0 |
| Gamma-carboxylation of protein precursors | R-HSA-159740 | 8.249569e-01 | 0.084 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.281564e-01 | 0.082 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 8.299935e-01 | 0.081 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 8.299935e-01 | 0.081 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 8.299935e-01 | 0.081 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 8.310915e-01 | 0.080 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 8.310915e-01 | 0.080 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 8.332257e-01 | 0.079 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 8.349871e-01 | 0.078 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.350290e-01 | 0.078 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 8.350290e-01 | 0.078 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.353931e-01 | 0.078 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 8.355230e-01 | 0.078 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 8.356536e-01 | 0.078 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 8.356536e-01 | 0.078 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 8.356536e-01 | 0.078 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 8.356536e-01 | 0.078 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 8.356536e-01 | 0.078 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 8.374402e-01 | 0.077 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 8.421748e-01 | 0.075 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.424374e-01 | 0.074 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 8.424374e-01 | 0.074 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 8.441658e-01 | 0.074 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 8.441658e-01 | 0.074 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 8.441658e-01 | 0.074 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 8.441658e-01 | 0.074 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 8.441658e-01 | 0.074 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 8.441658e-01 | 0.074 | 0 | 0 |
| Beta oxidation of palmitoyl-CoA to myristoyl-CoA | R-HSA-77305 | 8.441658e-01 | 0.074 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 8.441658e-01 | 0.074 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 8.441658e-01 | 0.074 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 8.441658e-01 | 0.074 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.441658e-01 | 0.074 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 8.441658e-01 | 0.074 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 8.441658e-01 | 0.074 | 0 | 0 |
| Gamma-carboxylation, transport, and amino-terminal cleavage of proteins | R-HSA-159854 | 8.441658e-01 | 0.074 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 8.496976e-01 | 0.071 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 8.496976e-01 | 0.071 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 8.496976e-01 | 0.071 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 8.496976e-01 | 0.071 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 8.496976e-01 | 0.071 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 8.499260e-01 | 0.071 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 8.526396e-01 | 0.069 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 8.526396e-01 | 0.069 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.526396e-01 | 0.069 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 8.526396e-01 | 0.069 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 8.526396e-01 | 0.069 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.530506e-01 | 0.069 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 8.540839e-01 | 0.068 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 8.540839e-01 | 0.068 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 8.540839e-01 | 0.068 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 8.540839e-01 | 0.068 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 8.540839e-01 | 0.068 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 8.544521e-01 | 0.068 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 8.544521e-01 | 0.068 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 8.572517e-01 | 0.067 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 8.596507e-01 | 0.066 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 8.603351e-01 | 0.065 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 8.612677e-01 | 0.065 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 8.612677e-01 | 0.065 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 8.612677e-01 | 0.065 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 8.612677e-01 | 0.065 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 8.612677e-01 | 0.065 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 8.612677e-01 | 0.065 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 8.612677e-01 | 0.065 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 8.612677e-01 | 0.065 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.621853e-01 | 0.064 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 8.625093e-01 | 0.064 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 8.625093e-01 | 0.064 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 8.625093e-01 | 0.064 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 8.626396e-01 | 0.064 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 8.626396e-01 | 0.064 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 8.626396e-01 | 0.064 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 8.626396e-01 | 0.064 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 8.634261e-01 | 0.064 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 8.649709e-01 | 0.063 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 8.649709e-01 | 0.063 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 8.660960e-01 | 0.062 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 8.662855e-01 | 0.062 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 8.668831e-01 | 0.062 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 8.697100e-01 | 0.061 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 8.718075e-01 | 0.060 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.718075e-01 | 0.060 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.718075e-01 | 0.060 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.745523e-01 | 0.058 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 8.745523e-01 | 0.058 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 8.745523e-01 | 0.058 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 8.745523e-01 | 0.058 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 8.745523e-01 | 0.058 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 8.745523e-01 | 0.058 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 8.751359e-01 | 0.058 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.751359e-01 | 0.058 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.751359e-01 | 0.058 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 8.751359e-01 | 0.058 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 8.764937e-01 | 0.057 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 8.764937e-01 | 0.057 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 8.764937e-01 | 0.057 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 8.764937e-01 | 0.057 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 8.764937e-01 | 0.057 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 8.764937e-01 | 0.057 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 8.781954e-01 | 0.056 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 8.805580e-01 | 0.055 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 8.805580e-01 | 0.055 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 8.837523e-01 | 0.054 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 8.840555e-01 | 0.054 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 8.843592e-01 | 0.053 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 8.846162e-01 | 0.053 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 8.846162e-01 | 0.053 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 8.846162e-01 | 0.053 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 8.855056e-01 | 0.053 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 8.855056e-01 | 0.053 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 8.855056e-01 | 0.053 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 8.860057e-01 | 0.053 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 8.868256e-01 | 0.052 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 8.883941e-01 | 0.051 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.900494e-01 | 0.051 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.900494e-01 | 0.051 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 8.900494e-01 | 0.051 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.900494e-01 | 0.051 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 8.900494e-01 | 0.051 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 8.900494e-01 | 0.051 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 8.900494e-01 | 0.051 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 8.900494e-01 | 0.051 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.934486e-01 | 0.049 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.934486e-01 | 0.049 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 8.955667e-01 | 0.048 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 8.955667e-01 | 0.048 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 8.955667e-01 | 0.048 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.955667e-01 | 0.048 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 8.955667e-01 | 0.048 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 8.955667e-01 | 0.048 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 8.955667e-01 | 0.048 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 8.982722e-01 | 0.047 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 9.015871e-01 | 0.045 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.015871e-01 | 0.045 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.016690e-01 | 0.045 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 9.021180e-01 | 0.045 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 9.021180e-01 | 0.045 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 9.021180e-01 | 0.045 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 9.021180e-01 | 0.045 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 9.021180e-01 | 0.045 | 0 | 0 |
| Activation of the phototransduction cascade | R-HSA-2485179 | 9.021180e-01 | 0.045 | 0 | 0 |
| Serotonin and melatonin biosynthesis | R-HSA-209931 | 9.021180e-01 | 0.045 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 9.021180e-01 | 0.045 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.021180e-01 | 0.045 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 9.021180e-01 | 0.045 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 9.021180e-01 | 0.045 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 9.021180e-01 | 0.045 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 9.025494e-01 | 0.045 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 9.025494e-01 | 0.045 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 9.037618e-01 | 0.044 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.037618e-01 | 0.044 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.042181e-01 | 0.044 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.047994e-01 | 0.043 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.047994e-01 | 0.043 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 9.047994e-01 | 0.043 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.079963e-01 | 0.042 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.090707e-01 | 0.041 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.090707e-01 | 0.041 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 9.128625e-01 | 0.040 | 0 | 0 |
| Heme assimilation | R-HSA-9927020 | 9.128625e-01 | 0.040 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 9.128625e-01 | 0.040 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 9.128625e-01 | 0.040 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 9.128625e-01 | 0.040 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 9.128625e-01 | 0.040 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.132643e-01 | 0.039 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.132643e-01 | 0.039 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.132643e-01 | 0.039 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 9.132643e-01 | 0.039 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 9.132643e-01 | 0.039 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 9.132643e-01 | 0.039 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.132643e-01 | 0.039 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.132643e-01 | 0.039 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.132643e-01 | 0.039 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.140373e-01 | 0.039 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.145103e-01 | 0.039 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.161500e-01 | 0.038 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 9.161808e-01 | 0.038 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 9.161808e-01 | 0.038 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.164124e-01 | 0.038 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.164124e-01 | 0.038 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.169250e-01 | 0.038 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.169291e-01 | 0.038 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.184846e-01 | 0.037 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.192914e-01 | 0.037 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.203516e-01 | 0.036 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.210186e-01 | 0.036 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.210186e-01 | 0.036 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 9.210186e-01 | 0.036 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.210186e-01 | 0.036 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.224281e-01 | 0.035 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 9.224281e-01 | 0.035 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.224281e-01 | 0.035 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 9.224281e-01 | 0.035 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 9.224281e-01 | 0.035 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 9.224281e-01 | 0.035 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.224281e-01 | 0.035 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 9.224281e-01 | 0.035 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.227039e-01 | 0.035 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.230020e-01 | 0.035 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 9.230020e-01 | 0.035 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.254816e-01 | 0.034 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.278650e-01 | 0.033 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 9.281163e-01 | 0.032 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.284539e-01 | 0.032 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.291127e-01 | 0.032 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.291127e-01 | 0.032 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.346081e-01 | 0.029 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 9.347744e-01 | 0.029 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.347744e-01 | 0.029 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.361812e-01 | 0.029 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.362922e-01 | 0.029 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.366401e-01 | 0.028 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 9.385186e-01 | 0.028 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 9.385258e-01 | 0.028 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 9.385258e-01 | 0.028 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.385258e-01 | 0.028 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.385258e-01 | 0.028 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 9.385258e-01 | 0.028 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 9.385258e-01 | 0.028 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.385258e-01 | 0.028 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.385258e-01 | 0.028 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 9.385258e-01 | 0.028 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 9.385258e-01 | 0.028 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.405414e-01 | 0.027 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.405414e-01 | 0.027 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.434018e-01 | 0.025 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 9.448653e-01 | 0.025 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 9.448653e-01 | 0.025 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 9.448653e-01 | 0.025 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.452754e-01 | 0.024 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 9.452754e-01 | 0.024 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.452754e-01 | 0.024 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.452754e-01 | 0.024 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 9.452754e-01 | 0.024 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.458253e-01 | 0.024 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.473600e-01 | 0.023 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 9.473600e-01 | 0.023 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.477916e-01 | 0.023 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 9.493479e-01 | 0.023 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.493479e-01 | 0.023 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.505810e-01 | 0.022 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.509070e-01 | 0.022 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 9.509070e-01 | 0.022 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 9.509070e-01 | 0.022 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.509070e-01 | 0.022 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 9.510209e-01 | 0.022 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.512843e-01 | 0.022 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.512843e-01 | 0.022 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 9.512843e-01 | 0.022 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 9.512843e-01 | 0.022 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.512843e-01 | 0.022 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.512843e-01 | 0.022 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 9.512843e-01 | 0.022 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 9.512843e-01 | 0.022 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.512843e-01 | 0.022 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.512843e-01 | 0.022 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 9.512843e-01 | 0.022 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.513400e-01 | 0.022 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.513400e-01 | 0.022 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.513400e-01 | 0.022 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.548800e-01 | 0.020 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.554191e-01 | 0.020 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.559704e-01 | 0.020 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.562406e-01 | 0.019 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.565894e-01 | 0.019 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 9.566337e-01 | 0.019 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 9.566337e-01 | 0.019 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.566337e-01 | 0.019 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.566337e-01 | 0.019 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.566337e-01 | 0.019 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.566337e-01 | 0.019 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 9.566337e-01 | 0.019 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.566337e-01 | 0.019 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.566337e-01 | 0.019 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.566337e-01 | 0.019 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.573116e-01 | 0.019 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.578779e-01 | 0.019 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.582895e-01 | 0.019 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.591566e-01 | 0.018 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.595326e-01 | 0.018 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.603946e-01 | 0.018 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.607893e-01 | 0.017 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.608382e-01 | 0.017 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.613960e-01 | 0.017 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.613960e-01 | 0.017 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.613960e-01 | 0.017 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.613960e-01 | 0.017 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.619318e-01 | 0.017 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.632806e-01 | 0.016 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.632806e-01 | 0.016 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.632806e-01 | 0.016 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.632945e-01 | 0.016 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.656355e-01 | 0.015 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 9.656355e-01 | 0.015 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.656355e-01 | 0.015 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.656355e-01 | 0.015 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 9.656355e-01 | 0.015 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.656355e-01 | 0.015 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.656355e-01 | 0.015 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.665761e-01 | 0.015 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.666937e-01 | 0.015 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.666937e-01 | 0.015 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.670031e-01 | 0.015 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.670854e-01 | 0.015 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.676904e-01 | 0.014 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.682942e-01 | 0.014 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.682942e-01 | 0.014 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.694097e-01 | 0.013 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.694097e-01 | 0.013 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.694097e-01 | 0.013 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.694097e-01 | 0.013 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 9.694097e-01 | 0.013 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.694097e-01 | 0.013 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.694097e-01 | 0.013 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.698003e-01 | 0.013 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.708041e-01 | 0.013 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.726265e-01 | 0.012 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.727696e-01 | 0.012 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.727696e-01 | 0.012 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.727696e-01 | 0.012 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 9.727696e-01 | 0.012 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.727696e-01 | 0.012 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 9.727696e-01 | 0.012 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.727696e-01 | 0.012 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.727696e-01 | 0.012 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.727696e-01 | 0.012 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.749876e-01 | 0.011 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.751965e-01 | 0.011 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.757606e-01 | 0.011 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.757606e-01 | 0.011 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 9.757606e-01 | 0.011 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.757606e-01 | 0.011 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.757606e-01 | 0.011 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.757606e-01 | 0.011 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 9.757606e-01 | 0.011 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.762335e-01 | 0.010 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.762631e-01 | 0.010 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.775323e-01 | 0.010 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.784232e-01 | 0.009 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.784232e-01 | 0.009 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 9.784232e-01 | 0.009 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.784232e-01 | 0.009 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.784232e-01 | 0.009 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.784232e-01 | 0.009 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.788375e-01 | 0.009 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.796544e-01 | 0.009 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.796544e-01 | 0.009 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.796544e-01 | 0.009 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.796544e-01 | 0.009 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.800774e-01 | 0.009 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.806491e-01 | 0.008 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.807213e-01 | 0.008 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.807935e-01 | 0.008 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.807935e-01 | 0.008 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.807935e-01 | 0.008 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.808990e-01 | 0.008 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.810973e-01 | 0.008 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.823120e-01 | 0.008 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.829035e-01 | 0.007 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.832486e-01 | 0.007 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.833311e-01 | 0.007 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.843905e-01 | 0.007 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.847819e-01 | 0.007 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.847819e-01 | 0.007 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.849186e-01 | 0.007 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.849359e-01 | 0.007 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.849760e-01 | 0.007 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.852368e-01 | 0.006 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.854648e-01 | 0.006 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.864539e-01 | 0.006 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.864539e-01 | 0.006 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.865194e-01 | 0.006 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.875613e-01 | 0.005 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.876946e-01 | 0.005 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.879230e-01 | 0.005 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.879424e-01 | 0.005 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 9.892673e-01 | 0.005 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.892673e-01 | 0.005 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.893983e-01 | 0.005 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.897069e-01 | 0.004 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.897562e-01 | 0.004 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.897562e-01 | 0.004 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.904332e-01 | 0.004 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.904468e-01 | 0.004 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.904468e-01 | 0.004 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.905511e-01 | 0.004 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.909760e-01 | 0.004 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 9.913288e-01 | 0.004 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.913605e-01 | 0.004 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.913931e-01 | 0.004 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.914967e-01 | 0.004 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.914967e-01 | 0.004 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.914967e-01 | 0.004 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.914967e-01 | 0.004 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.914967e-01 | 0.004 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.917718e-01 | 0.004 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.922372e-01 | 0.003 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.922548e-01 | 0.003 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.924092e-01 | 0.003 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.924312e-01 | 0.003 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.924312e-01 | 0.003 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.924312e-01 | 0.003 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.925683e-01 | 0.003 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.934866e-01 | 0.003 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.940010e-01 | 0.003 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.940036e-01 | 0.003 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.942659e-01 | 0.002 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.945315e-01 | 0.002 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.946628e-01 | 0.002 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.946628e-01 | 0.002 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.946628e-01 | 0.002 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.950650e-01 | 0.002 | 0 | 0 |
| Diseases associated with N-glycosylation of proteins | R-HSA-3781860 | 9.952495e-01 | 0.002 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.954862e-01 | 0.002 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.955473e-01 | 0.002 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.957718e-01 | 0.002 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.962366e-01 | 0.002 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.962366e-01 | 0.002 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 9.962366e-01 | 0.002 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.963773e-01 | 0.002 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.963773e-01 | 0.002 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.966504e-01 | 0.001 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.966504e-01 | 0.001 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.967332e-01 | 0.001 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.967332e-01 | 0.001 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.967332e-01 | 0.001 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.967332e-01 | 0.001 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.969738e-01 | 0.001 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.969763e-01 | 0.001 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.970547e-01 | 0.001 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.972495e-01 | 0.001 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.973466e-01 | 0.001 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.973466e-01 | 0.001 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.973466e-01 | 0.001 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.974727e-01 | 0.001 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 9.976071e-01 | 0.001 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 9.976071e-01 | 0.001 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.976384e-01 | 0.001 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.976384e-01 | 0.001 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.976384e-01 | 0.001 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.976903e-01 | 0.001 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.978000e-01 | 0.001 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.978072e-01 | 0.001 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of saturated fatty acids | R-HSA-77286 | 9.978981e-01 | 0.001 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.979924e-01 | 0.001 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.982395e-01 | 0.001 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.982498e-01 | 0.001 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.983350e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.984236e-01 | 0.001 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.984236e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.984236e-01 | 0.001 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.984500e-01 | 0.001 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.985182e-01 | 0.001 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.985182e-01 | 0.001 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.985182e-01 | 0.001 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.986214e-01 | 0.001 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.986812e-01 | 0.001 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.986970e-01 | 0.001 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.987060e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.987780e-01 | 0.001 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.988262e-01 | 0.001 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.988491e-01 | 0.001 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.988491e-01 | 0.001 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.989131e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.989640e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.989640e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.989777e-01 | 0.000 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.989833e-01 | 0.000 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.989833e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.990675e-01 | 0.000 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.991548e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.991591e-01 | 0.000 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.991591e-01 | 0.000 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.991726e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.992207e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.993206e-01 | 0.000 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.994168e-01 | 0.000 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.996238e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.996342e-01 | 0.000 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.996406e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.996468e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.996620e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.996648e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.997422e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.997706e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.997706e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.998106e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.998383e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.998508e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.998561e-01 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.998837e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.998986e-01 | 0.000 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.998986e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.999098e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999111e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.999197e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.999197e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999199e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.999286e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999295e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999325e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999360e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999480e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.999480e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999559e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999559e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999581e-01 | 0.000 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.999637e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.999721e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999757e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999778e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999823e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999843e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999886e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999951e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999951e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999953e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.999957e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999991e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999991e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999993e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999993e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999994e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.999996e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999997e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999998e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999999e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999999e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999999e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999999e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999999e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999999e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 1.000000e+00 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.530223e-08 | 7.597 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.530223e-08 | 7.597 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 2.087450e-07 | 6.680 | 1 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 3.753862e-07 | 6.426 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 5.496716e-07 | 6.260 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 8.553773e-07 | 6.068 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.912952e-06 | 5.718 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 4.632001e-06 | 5.334 | 1 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 5.132339e-06 | 5.290 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 8.726734e-06 | 5.059 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 7.796653e-06 | 5.108 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 8.652786e-06 | 5.063 | 1 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.584883e-05 | 4.800 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.519212e-05 | 4.818 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.601361e-05 | 4.796 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.988469e-05 | 4.525 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.266031e-05 | 4.486 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.266031e-05 | 4.486 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 3.990606e-05 | 4.399 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 4.877160e-05 | 4.312 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 5.091485e-05 | 4.293 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 5.364112e-05 | 4.271 | 1 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 6.299507e-05 | 4.201 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 6.948259e-05 | 4.158 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 6.980686e-05 | 4.156 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 7.062992e-05 | 4.151 | 0 | 0 |
| M Phase | R-HSA-68886 | 7.214123e-05 | 4.142 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 7.669176e-05 | 4.115 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 8.117931e-05 | 4.091 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.113626e-04 | 3.953 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.211643e-04 | 3.917 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.283227e-04 | 3.892 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.468948e-04 | 3.833 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.193218e-04 | 3.659 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.203331e-04 | 3.657 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.651899e-04 | 3.576 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.702329e-04 | 3.568 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 3.280453e-04 | 3.484 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 3.854575e-04 | 3.414 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 4.196880e-04 | 3.377 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 4.196880e-04 | 3.377 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 4.605013e-04 | 3.337 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 4.807278e-04 | 3.318 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 5.275322e-04 | 3.278 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 5.138918e-04 | 3.289 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 5.379079e-04 | 3.269 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 5.587220e-04 | 3.253 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 5.969579e-04 | 3.224 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 7.627568e-04 | 3.118 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 7.875117e-04 | 3.104 | 1 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 8.570863e-04 | 3.067 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 8.737259e-04 | 3.059 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.515407e-04 | 3.022 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.148079e-03 | 2.940 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.120591e-03 | 2.951 | 1 | 1 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.281061e-03 | 2.892 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.296495e-03 | 2.887 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.432959e-03 | 2.844 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.464788e-03 | 2.834 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.592808e-03 | 2.798 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.716319e-03 | 2.765 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.795035e-03 | 2.746 | 1 | 1 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 1.794487e-03 | 2.746 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.010249e-03 | 2.697 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 2.217850e-03 | 2.654 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 2.217850e-03 | 2.654 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 2.566844e-03 | 2.591 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 2.635682e-03 | 2.579 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.662344e-03 | 2.575 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 3.149694e-03 | 2.502 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 3.518408e-03 | 2.454 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 3.518408e-03 | 2.454 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 3.360369e-03 | 2.474 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 3.353941e-03 | 2.474 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.398885e-03 | 2.469 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 3.529625e-03 | 2.452 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 3.784621e-03 | 2.422 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 3.973104e-03 | 2.401 | 1 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 3.989071e-03 | 2.399 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 4.031337e-03 | 2.395 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 4.336059e-03 | 2.363 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 4.859405e-03 | 2.313 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 4.689991e-03 | 2.329 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 4.859405e-03 | 2.313 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 4.648703e-03 | 2.333 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 5.673533e-03 | 2.246 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 5.859745e-03 | 2.232 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 5.989003e-03 | 2.223 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 6.143041e-03 | 2.212 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 6.399323e-03 | 2.194 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 6.746890e-03 | 2.171 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 6.875353e-03 | 2.163 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 7.152597e-03 | 2.146 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 7.425586e-03 | 2.129 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 7.563759e-03 | 2.121 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 7.934718e-03 | 2.100 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 7.644618e-03 | 2.117 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 7.602315e-03 | 2.119 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 7.990678e-03 | 2.097 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 8.006408e-03 | 2.097 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 8.116182e-03 | 2.091 | 0 | 0 |
| Depurination | R-HSA-73927 | 8.285865e-03 | 2.082 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 8.973051e-03 | 2.047 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.061705e-02 | 1.974 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.063709e-02 | 1.973 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 9.880446e-03 | 2.005 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 1.071406e-02 | 1.970 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.136462e-02 | 1.944 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.136462e-02 | 1.944 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.195384e-02 | 1.922 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.273075e-02 | 1.895 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.212700e-02 | 1.916 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.290009e-02 | 1.889 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 1.308402e-02 | 1.883 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.308402e-02 | 1.883 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.308402e-02 | 1.883 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.347954e-02 | 1.870 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 1.416375e-02 | 1.849 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.421910e-02 | 1.847 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.426081e-02 | 1.846 | 1 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.475161e-02 | 1.831 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.536765e-02 | 1.813 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.527821e-02 | 1.816 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.527821e-02 | 1.816 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.621760e-02 | 1.790 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.700841e-02 | 1.769 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 1.722532e-02 | 1.764 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 1.722532e-02 | 1.764 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.758847e-02 | 1.755 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 1.917559e-02 | 1.717 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.170583e-02 | 1.663 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.088388e-02 | 1.680 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.088712e-02 | 1.680 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.293997e-02 | 1.639 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 2.364563e-02 | 1.626 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.401809e-02 | 1.619 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.460782e-02 | 1.609 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.460782e-02 | 1.609 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.479277e-02 | 1.606 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.527460e-02 | 1.597 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.527460e-02 | 1.597 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 2.548509e-02 | 1.594 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 2.548509e-02 | 1.594 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.591659e-02 | 1.586 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 2.591659e-02 | 1.586 | 1 | 1 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 2.591659e-02 | 1.586 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.006254e-02 | 1.522 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 3.095157e-02 | 1.509 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 3.112104e-02 | 1.507 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 3.165889e-02 | 1.500 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 3.204945e-02 | 1.494 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 3.313157e-02 | 1.480 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.486907e-02 | 1.458 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.587715e-02 | 1.445 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 3.694778e-02 | 1.432 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 4.199342e-02 | 1.377 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.005967e-02 | 1.397 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 4.152118e-02 | 1.382 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 4.054424e-02 | 1.392 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 3.985030e-02 | 1.400 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 4.190269e-02 | 1.378 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 3.841056e-02 | 1.416 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 3.819975e-02 | 1.418 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 4.131153e-02 | 1.384 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 4.230320e-02 | 1.374 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 4.256293e-02 | 1.371 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 4.306118e-02 | 1.366 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 4.306118e-02 | 1.366 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 5.043887e-02 | 1.297 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 5.043887e-02 | 1.297 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 5.043887e-02 | 1.297 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 5.043887e-02 | 1.297 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 5.043887e-02 | 1.297 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 5.043887e-02 | 1.297 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 5.043887e-02 | 1.297 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 5.043887e-02 | 1.297 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 5.043887e-02 | 1.297 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 5.043887e-02 | 1.297 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 5.043887e-02 | 1.297 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 4.790789e-02 | 1.320 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 4.533305e-02 | 1.344 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 4.679313e-02 | 1.330 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.642197e-02 | 1.333 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 5.075249e-02 | 1.295 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 4.913329e-02 | 1.309 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 4.533305e-02 | 1.344 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 5.043887e-02 | 1.297 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 5.075249e-02 | 1.295 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 4.790789e-02 | 1.320 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 5.488872e-02 | 1.261 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 5.671539e-02 | 1.246 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 5.693584e-02 | 1.245 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 5.716285e-02 | 1.243 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 5.751513e-02 | 1.240 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.790011e-02 | 1.237 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.790011e-02 | 1.237 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 5.790011e-02 | 1.237 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 5.793409e-02 | 1.237 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 5.793409e-02 | 1.237 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 6.165332e-02 | 1.210 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 6.165332e-02 | 1.210 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 6.165332e-02 | 1.210 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 6.346464e-02 | 1.197 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 6.346464e-02 | 1.197 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 6.373054e-02 | 1.196 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 7.441270e-02 | 1.128 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 7.441270e-02 | 1.128 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 6.635408e-02 | 1.178 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 7.590575e-02 | 1.120 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 7.590575e-02 | 1.120 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 7.590575e-02 | 1.120 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 7.590575e-02 | 1.120 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 7.073764e-02 | 1.150 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 6.537914e-02 | 1.185 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 7.005354e-02 | 1.155 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 6.953190e-02 | 1.158 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 7.325592e-02 | 1.135 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 6.974733e-02 | 1.156 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 6.593185e-02 | 1.181 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 7.701207e-02 | 1.113 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 7.845510e-02 | 1.105 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 7.865478e-02 | 1.104 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 7.972898e-02 | 1.098 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 8.180000e-02 | 1.087 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 8.341397e-02 | 1.079 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 8.367565e-02 | 1.077 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 8.615898e-02 | 1.065 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 8.739766e-02 | 1.059 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 9.010599e-02 | 1.045 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 9.258196e-02 | 1.033 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 9.258196e-02 | 1.033 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 9.386377e-02 | 1.028 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 9.386377e-02 | 1.028 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 9.386377e-02 | 1.028 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 9.439219e-02 | 1.025 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 9.599532e-02 | 1.018 | 1 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 9.687369e-02 | 1.014 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 9.687369e-02 | 1.014 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 9.709773e-02 | 1.013 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 9.854544e-02 | 1.006 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.012215e-01 | 0.995 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 1.120750e-01 | 0.950 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.120750e-01 | 0.950 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.063498e-01 | 0.973 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.151191e-01 | 0.939 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.151191e-01 | 0.939 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.034149e-01 | 0.985 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.120750e-01 | 0.950 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.014252e-01 | 0.994 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.012215e-01 | 0.995 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 1.012215e-01 | 0.995 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.174209e-01 | 0.930 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.163106e-01 | 0.934 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.120750e-01 | 0.950 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.147830e-01 | 0.940 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.193880e-01 | 0.923 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.209456e-01 | 0.917 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 1.209817e-01 | 0.917 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.209817e-01 | 0.917 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.219096e-01 | 0.914 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.222253e-01 | 0.913 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.224211e-01 | 0.912 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.224401e-01 | 0.912 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 1.237570e-01 | 0.907 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.302067e-01 | 0.885 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.302067e-01 | 0.885 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 1.302067e-01 | 0.885 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 1.302067e-01 | 0.885 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 1.302067e-01 | 0.885 | 0 | 0 |
| CASP5 inflammasome assembly | R-HSA-9948011 | 1.635691e-01 | 0.786 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.635691e-01 | 0.786 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.635691e-01 | 0.786 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.635691e-01 | 0.786 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.635691e-01 | 0.786 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 1.635691e-01 | 0.786 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.635691e-01 | 0.786 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.635691e-01 | 0.786 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 1.635691e-01 | 0.786 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.635691e-01 | 0.786 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.635691e-01 | 0.786 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.635691e-01 | 0.786 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.608012e-01 | 0.794 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 1.608012e-01 | 0.794 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.364209e-01 | 0.865 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.364209e-01 | 0.865 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.364209e-01 | 0.865 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.526066e-01 | 0.816 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.338019e-01 | 0.874 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 1.472391e-01 | 0.832 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.612229e-01 | 0.793 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.398676e-01 | 0.854 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.518063e-01 | 0.819 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.319043e-01 | 0.880 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.526066e-01 | 0.816 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.319043e-01 | 0.880 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.598972e-01 | 0.796 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.398676e-01 | 0.854 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.612229e-01 | 0.793 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.520067e-01 | 0.818 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.530584e-01 | 0.815 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.608012e-01 | 0.794 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.614501e-01 | 0.792 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.635691e-01 | 0.786 | 0 | 0 |
| Proton/oligopeptide cotransporters | R-HSA-427975 | 1.608012e-01 | 0.794 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.557147e-01 | 0.808 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.472391e-01 | 0.832 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.598972e-01 | 0.796 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.560288e-01 | 0.807 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.394708e-01 | 0.856 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.472391e-01 | 0.832 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.364209e-01 | 0.865 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.593860e-01 | 0.798 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 1.520067e-01 | 0.818 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.504953e-01 | 0.822 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.456106e-01 | 0.837 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.526066e-01 | 0.816 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.552595e-01 | 0.809 | 1 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 1.641807e-01 | 0.785 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 1.641807e-01 | 0.785 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.641807e-01 | 0.785 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.350351e-01 | 0.629 | 0 | 0 |
| Defective GALE causes EDG | R-HSA-5609977 | 2.350351e-01 | 0.629 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 2.350351e-01 | 0.629 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.350351e-01 | 0.629 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 2.350351e-01 | 0.629 | 0 | 0 |
| Defective ALG9 causes CDG-1l | R-HSA-4720454 | 3.003989e-01 | 0.522 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 3.003989e-01 | 0.522 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 3.003989e-01 | 0.522 | 0 | 0 |
| Defective DHDDS causes RP59 | R-HSA-4755609 | 3.003989e-01 | 0.522 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.003989e-01 | 0.522 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.003989e-01 | 0.522 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 3.003989e-01 | 0.522 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.003989e-01 | 0.522 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 1.925192e-01 | 0.716 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 3.601810e-01 | 0.443 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 3.601810e-01 | 0.443 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 3.601810e-01 | 0.443 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 3.601810e-01 | 0.443 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 3.601810e-01 | 0.443 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 3.601810e-01 | 0.443 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 3.601810e-01 | 0.443 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 3.601810e-01 | 0.443 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 3.601810e-01 | 0.443 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.734354e-01 | 0.761 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 2.577283e-01 | 0.589 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.577283e-01 | 0.589 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 1.956464e-01 | 0.709 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 1.694743e-01 | 0.771 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 2.905699e-01 | 0.537 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.905699e-01 | 0.537 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.148579e-01 | 0.382 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 4.148579e-01 | 0.382 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.148579e-01 | 0.382 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.148579e-01 | 0.382 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.148579e-01 | 0.382 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 4.148579e-01 | 0.382 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.049881e-01 | 0.688 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.049881e-01 | 0.688 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 1.757170e-01 | 0.755 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 1.757170e-01 | 0.755 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.655980e-01 | 0.576 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.769678e-01 | 0.752 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 2.060817e-01 | 0.686 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.895948e-01 | 0.538 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 4.648653e-01 | 0.333 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 4.648653e-01 | 0.333 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 4.648653e-01 | 0.333 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 4.648653e-01 | 0.333 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 2.218717e-01 | 0.654 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 3.137370e-01 | 0.503 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.380119e-01 | 0.623 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.380119e-01 | 0.623 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 2.812185e-01 | 0.551 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 3.871619e-01 | 0.412 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 3.871619e-01 | 0.412 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 3.871619e-01 | 0.412 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 3.871619e-01 | 0.412 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 3.379204e-01 | 0.471 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 3.379204e-01 | 0.471 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.711753e-01 | 0.567 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.881152e-01 | 0.540 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 4.181423e-01 | 0.379 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 4.181423e-01 | 0.379 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 4.181423e-01 | 0.379 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 4.181423e-01 | 0.379 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 4.181423e-01 | 0.379 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 5.106017e-01 | 0.292 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 5.106017e-01 | 0.292 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 5.106017e-01 | 0.292 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 5.106017e-01 | 0.292 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 5.106017e-01 | 0.292 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.106017e-01 | 0.292 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 5.106017e-01 | 0.292 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 3.052390e-01 | 0.515 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.408621e-01 | 0.467 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.408621e-01 | 0.467 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 3.860365e-01 | 0.413 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.534065e-01 | 0.596 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.534065e-01 | 0.596 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.982613e-01 | 0.703 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 3.608873e-01 | 0.443 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.608873e-01 | 0.443 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.608873e-01 | 0.443 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 3.398782e-01 | 0.469 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 4.098034e-01 | 0.387 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 2.438354e-01 | 0.613 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 4.332795e-01 | 0.363 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 4.775664e-01 | 0.321 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.524316e-01 | 0.258 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 5.524316e-01 | 0.258 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 5.524316e-01 | 0.258 | 0 | 0 |
| Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) | R-HSA-5619070 | 5.524316e-01 | 0.258 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 5.524316e-01 | 0.258 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 3.135992e-01 | 0.504 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.298489e-01 | 0.482 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 3.479677e-01 | 0.458 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 4.564021e-01 | 0.341 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 4.403022e-01 | 0.356 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.058576e-01 | 0.296 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 5.058576e-01 | 0.296 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 3.761017e-01 | 0.425 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 4.227868e-01 | 0.374 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 5.331316e-01 | 0.273 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 5.906885e-01 | 0.229 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 5.906885e-01 | 0.229 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 5.906885e-01 | 0.229 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 5.906885e-01 | 0.229 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 5.906885e-01 | 0.229 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 5.906885e-01 | 0.229 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 5.906885e-01 | 0.229 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.621750e-01 | 0.335 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 5.231348e-01 | 0.281 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 5.231348e-01 | 0.281 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 5.231348e-01 | 0.281 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 4.927374e-01 | 0.307 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 5.593557e-01 | 0.252 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.078027e-01 | 0.294 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 4.855679e-01 | 0.314 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 4.576890e-01 | 0.339 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 5.280265e-01 | 0.277 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 5.319888e-01 | 0.274 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 5.441226e-01 | 0.264 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 5.650311e-01 | 0.248 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 5.650311e-01 | 0.248 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 6.256773e-01 | 0.204 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 6.256773e-01 | 0.204 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 6.256773e-01 | 0.204 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.256773e-01 | 0.204 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 5.354757e-01 | 0.271 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 5.851145e-01 | 0.233 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 6.085859e-01 | 0.216 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 6.085859e-01 | 0.216 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 5.933875e-01 | 0.227 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 6.045952e-01 | 0.219 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 6.043848e-01 | 0.219 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 6.128359e-01 | 0.213 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 6.203433e-01 | 0.207 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.315839e-01 | 0.200 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 6.315839e-01 | 0.200 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 6.576772e-01 | 0.182 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 6.346470e-01 | 0.197 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 6.366696e-01 | 0.196 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 6.521545e-01 | 0.186 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.535123e-01 | 0.185 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.853526e-01 | 0.545 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 3.398782e-01 | 0.469 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.206456e-01 | 0.376 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.208706e-01 | 0.494 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 2.745266e-01 | 0.561 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 2.745266e-01 | 0.561 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 2.745266e-01 | 0.561 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 2.508671e-01 | 0.601 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 6.043848e-01 | 0.219 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 4.008279e-01 | 0.397 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 4.757308e-01 | 0.323 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 3.137370e-01 | 0.503 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 3.860365e-01 | 0.413 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 5.013742e-01 | 0.300 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 4.126890e-01 | 0.384 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 3.909782e-01 | 0.408 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 6.045952e-01 | 0.219 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 6.043848e-01 | 0.219 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 4.008279e-01 | 0.397 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 4.270158e-01 | 0.370 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.621750e-01 | 0.335 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 5.053283e-01 | 0.296 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 2.508671e-01 | 0.601 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 2.438354e-01 | 0.613 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 2.905699e-01 | 0.537 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.812185e-01 | 0.551 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 4.442631e-01 | 0.352 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 4.311643e-01 | 0.365 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 5.593557e-01 | 0.252 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 5.443634e-01 | 0.264 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.768308e-01 | 0.558 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 5.454734e-01 | 0.263 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 3.257655e-01 | 0.487 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 6.085859e-01 | 0.216 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 2.905699e-01 | 0.537 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.232213e-01 | 0.490 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 4.564021e-01 | 0.341 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 5.331316e-01 | 0.273 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 4.739260e-01 | 0.324 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 4.993422e-01 | 0.302 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.587921e-01 | 0.253 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.587921e-01 | 0.253 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 5.876040e-01 | 0.231 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 6.043848e-01 | 0.219 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.164881e-01 | 0.665 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 5.610852e-01 | 0.251 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 6.576772e-01 | 0.182 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.174950e-01 | 0.663 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.734354e-01 | 0.761 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 3.620493e-01 | 0.441 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 4.181423e-01 | 0.379 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 5.106017e-01 | 0.292 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.398782e-01 | 0.469 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 2.340322e-01 | 0.631 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 5.524316e-01 | 0.258 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 5.058576e-01 | 0.296 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 5.058576e-01 | 0.296 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 6.256773e-01 | 0.204 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 6.045952e-01 | 0.219 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 6.057119e-01 | 0.218 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 6.286243e-01 | 0.202 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 3.380195e-01 | 0.471 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 2.430106e-01 | 0.614 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 2.430106e-01 | 0.614 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 1.769678e-01 | 0.752 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 4.181423e-01 | 0.379 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 4.181423e-01 | 0.379 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 4.979184e-01 | 0.303 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 5.528308e-01 | 0.257 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 5.941689e-01 | 0.226 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 5.045696e-01 | 0.297 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 2.175527e-01 | 0.662 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 4.483060e-01 | 0.348 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 6.045952e-01 | 0.219 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 6.234596e-01 | 0.205 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 2.881152e-01 | 0.540 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 2.577283e-01 | 0.589 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 1.869575e-01 | 0.728 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 2.218717e-01 | 0.654 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 3.137370e-01 | 0.503 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 2.711753e-01 | 0.567 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 5.106017e-01 | 0.292 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 4.775664e-01 | 0.321 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.331316e-01 | 0.273 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.331316e-01 | 0.273 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 4.269441e-01 | 0.370 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 6.256773e-01 | 0.204 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 4.602120e-01 | 0.337 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 4.791163e-01 | 0.320 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 5.719343e-01 | 0.243 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 4.181423e-01 | 0.379 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 5.058576e-01 | 0.296 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 6.291423e-01 | 0.201 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.869575e-01 | 0.728 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 5.443634e-01 | 0.264 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 4.500559e-01 | 0.347 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.648653e-01 | 0.333 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 4.648653e-01 | 0.333 | 0 | 0 |
| Activation of C3 and C5 | R-HSA-174577 | 4.648653e-01 | 0.333 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.106017e-01 | 0.292 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.934473e-01 | 0.713 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.534065e-01 | 0.596 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 4.403022e-01 | 0.356 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.339475e-01 | 0.476 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 5.906885e-01 | 0.229 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 5.906885e-01 | 0.229 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 5.116838e-01 | 0.291 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 5.443634e-01 | 0.264 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 5.845100e-01 | 0.233 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 6.315839e-01 | 0.200 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 6.315839e-01 | 0.200 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 3.379204e-01 | 0.471 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 6.256773e-01 | 0.204 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 5.331316e-01 | 0.273 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.609035e-01 | 0.584 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 3.062518e-01 | 0.514 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 5.058576e-01 | 0.296 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 5.348725e-01 | 0.272 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 3.876426e-01 | 0.412 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 3.358136e-01 | 0.474 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 4.685029e-01 | 0.329 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 5.650311e-01 | 0.248 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.070568e-01 | 0.684 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 3.232213e-01 | 0.490 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 5.976493e-01 | 0.224 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 5.046761e-01 | 0.297 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 3.620493e-01 | 0.441 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.914094e-01 | 0.535 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.903322e-01 | 0.310 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.442486e-01 | 0.612 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 4.597573e-01 | 0.337 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 1.846178e-01 | 0.734 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.350351e-01 | 0.629 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 2.350351e-01 | 0.629 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.003989e-01 | 0.522 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.003989e-01 | 0.522 | 0 | 0 |
| The IPAF inflammasome | R-HSA-844623 | 3.601810e-01 | 0.443 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.601810e-01 | 0.443 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 1.694743e-01 | 0.771 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 2.905699e-01 | 0.537 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.895948e-01 | 0.538 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 4.648653e-01 | 0.333 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 3.379204e-01 | 0.471 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 3.379204e-01 | 0.471 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 5.106017e-01 | 0.292 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 5.106017e-01 | 0.292 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 4.483060e-01 | 0.348 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 4.483060e-01 | 0.348 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 2.916270e-01 | 0.535 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.573161e-01 | 0.447 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 4.206456e-01 | 0.376 | 0 | 0 |
| Kinesins | R-HSA-983189 | 4.053505e-01 | 0.392 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 4.789740e-01 | 0.320 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 5.331316e-01 | 0.273 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 5.116838e-01 | 0.291 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 5.771813e-01 | 0.239 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 5.803219e-01 | 0.236 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 5.941689e-01 | 0.226 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 6.045952e-01 | 0.219 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 6.486149e-01 | 0.188 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 5.280265e-01 | 0.277 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 3.841811e-01 | 0.415 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 2.910070e-01 | 0.536 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.035018e-01 | 0.691 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 5.443634e-01 | 0.264 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 4.402015e-01 | 0.356 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 2.184993e-01 | 0.661 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 4.096662e-01 | 0.388 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 4.227868e-01 | 0.374 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 4.493615e-01 | 0.347 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 2.905699e-01 | 0.537 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 2.461928e-01 | 0.609 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 6.490791e-01 | 0.188 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 4.648653e-01 | 0.333 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 4.775664e-01 | 0.321 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 4.340333e-01 | 0.362 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.593557e-01 | 0.252 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 4.780414e-01 | 0.321 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 5.427097e-01 | 0.265 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 4.283726e-01 | 0.368 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 2.655980e-01 | 0.576 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 4.197083e-01 | 0.377 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.648603e-01 | 0.783 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 6.239107e-01 | 0.205 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 2.577283e-01 | 0.589 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.956464e-01 | 0.709 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 4.648653e-01 | 0.333 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 2.247271e-01 | 0.648 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.881152e-01 | 0.540 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 4.181423e-01 | 0.379 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 4.564021e-01 | 0.341 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 5.906885e-01 | 0.229 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 5.906885e-01 | 0.229 | 0 | 0 |
| Heme assimilation | R-HSA-9927020 | 5.593557e-01 | 0.252 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 3.608873e-01 | 0.443 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 4.611286e-01 | 0.336 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 3.232213e-01 | 0.490 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 5.231348e-01 | 0.281 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.354577e-01 | 0.628 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.777631e-01 | 0.556 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.956464e-01 | 0.709 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 4.648653e-01 | 0.333 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 3.009695e-01 | 0.521 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 6.576772e-01 | 0.182 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 2.418593e-01 | 0.616 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 5.165603e-01 | 0.287 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 5.845100e-01 | 0.233 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 3.009695e-01 | 0.521 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 2.673231e-01 | 0.573 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 2.350351e-01 | 0.629 | 0 | 0 |
| SLC-mediated transport of oligopeptides | R-HSA-9959399 | 2.249456e-01 | 0.648 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 3.601810e-01 | 0.443 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 1.956464e-01 | 0.709 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 4.148579e-01 | 0.382 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 3.232213e-01 | 0.490 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.234974e-01 | 0.651 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.895948e-01 | 0.538 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 3.554754e-01 | 0.449 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 2.881152e-01 | 0.540 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 3.208706e-01 | 0.494 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 5.524316e-01 | 0.258 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 3.563345e-01 | 0.448 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 5.906885e-01 | 0.229 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.775221e-01 | 0.321 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.593557e-01 | 0.252 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 5.348725e-01 | 0.272 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 5.650311e-01 | 0.248 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 5.845100e-01 | 0.233 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.256773e-01 | 0.204 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 6.256773e-01 | 0.204 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 6.043848e-01 | 0.219 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 6.234596e-01 | 0.205 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.315839e-01 | 0.200 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 6.576772e-01 | 0.182 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 6.576772e-01 | 0.182 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.896381e-01 | 0.722 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 2.120301e-01 | 0.674 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 2.161724e-01 | 0.665 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 4.467156e-01 | 0.350 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 3.608873e-01 | 0.443 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 3.257655e-01 | 0.487 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 4.903322e-01 | 0.310 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.057394e-01 | 0.687 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.343259e-01 | 0.630 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 3.052390e-01 | 0.515 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 4.625146e-01 | 0.335 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 3.860365e-01 | 0.413 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 3.562937e-01 | 0.448 | 1 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 5.166018e-01 | 0.287 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.232213e-01 | 0.490 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 2.218717e-01 | 0.654 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.711753e-01 | 0.567 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 5.524316e-01 | 0.258 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 5.845100e-01 | 0.233 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 6.576772e-01 | 0.182 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 6.264218e-01 | 0.203 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 6.085859e-01 | 0.216 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 5.348725e-01 | 0.272 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 6.236760e-01 | 0.205 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 6.264218e-01 | 0.203 | 0 | 0 |
| The AIM2 inflammasome | R-HSA-844615 | 3.003989e-01 | 0.522 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 2.249456e-01 | 0.648 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.184993e-01 | 0.661 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 4.332795e-01 | 0.363 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 5.524316e-01 | 0.258 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 5.524316e-01 | 0.258 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 3.380195e-01 | 0.471 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 4.270158e-01 | 0.370 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 5.331316e-01 | 0.273 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 5.906885e-01 | 0.229 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 5.593557e-01 | 0.252 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 6.256773e-01 | 0.204 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 6.256773e-01 | 0.204 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 6.315839e-01 | 0.200 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 6.576772e-01 | 0.182 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 6.465402e-01 | 0.189 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.932491e-01 | 0.714 | 1 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 5.892367e-01 | 0.230 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 5.941689e-01 | 0.226 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.996597e-01 | 0.398 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 5.650311e-01 | 0.248 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 6.315839e-01 | 0.200 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 4.181423e-01 | 0.379 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.734354e-01 | 0.761 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 4.483060e-01 | 0.348 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 5.058576e-01 | 0.296 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 4.564021e-01 | 0.341 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 6.315839e-01 | 0.200 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 6.576772e-01 | 0.182 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.917934e-01 | 0.717 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 4.564021e-01 | 0.341 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 2.249456e-01 | 0.648 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.577283e-01 | 0.589 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 4.648653e-01 | 0.333 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 4.098034e-01 | 0.387 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 3.747834e-01 | 0.426 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 5.058576e-01 | 0.296 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 5.906885e-01 | 0.229 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 5.906885e-01 | 0.229 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 5.280265e-01 | 0.277 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 6.576772e-01 | 0.182 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 6.576772e-01 | 0.182 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 6.576772e-01 | 0.182 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 5.351331e-01 | 0.272 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 5.528308e-01 | 0.257 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 3.009695e-01 | 0.521 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 3.922447e-01 | 0.406 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 3.649603e-01 | 0.438 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 5.013742e-01 | 0.300 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 5.013742e-01 | 0.300 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.528235e-01 | 0.452 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 5.972600e-01 | 0.224 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 4.688929e-01 | 0.329 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 2.905699e-01 | 0.537 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 4.181423e-01 | 0.379 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 3.608873e-01 | 0.443 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 3.922447e-01 | 0.406 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 4.979184e-01 | 0.303 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 5.650311e-01 | 0.248 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 5.851145e-01 | 0.233 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 6.535123e-01 | 0.185 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 6.207436e-01 | 0.207 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 6.315839e-01 | 0.200 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 3.554754e-01 | 0.449 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 4.270158e-01 | 0.370 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.765493e-01 | 0.558 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 5.845100e-01 | 0.233 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 5.534061e-01 | 0.257 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 5.524316e-01 | 0.258 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 5.906885e-01 | 0.229 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 5.348725e-01 | 0.272 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 5.183501e-01 | 0.285 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.315839e-01 | 0.200 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 3.216775e-01 | 0.493 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.648603e-01 | 0.783 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 6.085859e-01 | 0.216 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 3.479677e-01 | 0.458 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 5.593557e-01 | 0.252 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 6.085859e-01 | 0.216 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 5.704141e-01 | 0.244 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 3.298489e-01 | 0.482 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 5.593557e-01 | 0.252 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.232213e-01 | 0.490 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 5.845100e-01 | 0.233 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 5.639111e-01 | 0.249 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 4.483060e-01 | 0.348 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 5.845100e-01 | 0.233 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 4.775664e-01 | 0.321 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 6.315839e-01 | 0.200 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 5.593557e-01 | 0.252 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 4.648653e-01 | 0.333 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 6.085859e-01 | 0.216 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 6.582392e-01 | 0.182 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 6.593046e-01 | 0.181 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 6.671919e-01 | 0.176 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 6.671919e-01 | 0.176 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 6.671919e-01 | 0.176 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 6.694292e-01 | 0.174 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 6.696721e-01 | 0.174 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 6.718123e-01 | 0.173 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 6.718123e-01 | 0.173 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 6.743859e-01 | 0.171 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 6.743859e-01 | 0.171 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 6.743859e-01 | 0.171 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 6.743859e-01 | 0.171 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 6.743859e-01 | 0.171 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.743859e-01 | 0.171 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 6.755187e-01 | 0.170 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.756265e-01 | 0.170 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 6.762770e-01 | 0.170 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 6.762770e-01 | 0.170 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 6.762770e-01 | 0.170 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 6.762770e-01 | 0.170 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 6.762770e-01 | 0.170 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 6.762770e-01 | 0.170 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 6.762770e-01 | 0.170 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 6.781377e-01 | 0.169 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 6.783359e-01 | 0.169 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 6.835026e-01 | 0.165 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 6.869432e-01 | 0.163 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 6.869432e-01 | 0.163 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 6.869432e-01 | 0.163 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 6.869432e-01 | 0.163 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 6.869432e-01 | 0.163 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 6.869432e-01 | 0.163 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 6.869432e-01 | 0.163 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 6.869432e-01 | 0.163 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 6.869432e-01 | 0.163 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 6.869432e-01 | 0.163 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 6.869432e-01 | 0.163 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 6.869432e-01 | 0.163 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 6.869432e-01 | 0.163 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 6.869432e-01 | 0.163 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 6.869432e-01 | 0.163 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 6.869432e-01 | 0.163 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 6.869432e-01 | 0.163 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 6.869432e-01 | 0.163 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 6.870964e-01 | 0.163 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 6.879430e-01 | 0.162 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 6.884451e-01 | 0.162 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 6.926160e-01 | 0.160 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 6.926160e-01 | 0.160 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 6.926160e-01 | 0.160 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 6.942247e-01 | 0.158 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 6.942247e-01 | 0.158 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 6.942247e-01 | 0.158 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 6.942247e-01 | 0.158 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 6.942247e-01 | 0.158 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 6.942247e-01 | 0.158 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 6.942247e-01 | 0.158 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 6.954677e-01 | 0.158 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 6.957840e-01 | 0.158 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 6.959088e-01 | 0.157 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 6.959088e-01 | 0.157 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 6.959088e-01 | 0.157 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 6.959088e-01 | 0.157 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 6.959088e-01 | 0.157 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 6.959088e-01 | 0.157 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 6.959088e-01 | 0.157 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 6.959088e-01 | 0.157 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 7.010170e-01 | 0.154 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 7.010170e-01 | 0.154 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 7.083249e-01 | 0.150 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 7.083249e-01 | 0.150 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 7.083249e-01 | 0.150 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 7.094634e-01 | 0.149 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 7.095850e-01 | 0.149 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 7.095850e-01 | 0.149 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 7.095850e-01 | 0.149 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 7.095850e-01 | 0.149 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 7.095850e-01 | 0.149 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 7.095850e-01 | 0.149 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.130532e-01 | 0.147 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 7.130532e-01 | 0.147 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.130532e-01 | 0.147 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 7.130532e-01 | 0.147 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.130532e-01 | 0.147 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.130532e-01 | 0.147 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 7.130532e-01 | 0.147 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.130532e-01 | 0.147 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 7.137087e-01 | 0.146 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 7.137087e-01 | 0.146 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 7.137087e-01 | 0.146 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 7.137087e-01 | 0.146 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 7.137087e-01 | 0.146 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 7.137087e-01 | 0.146 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.137087e-01 | 0.146 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 7.137087e-01 | 0.146 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 7.137087e-01 | 0.146 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 7.137087e-01 | 0.146 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.137087e-01 | 0.146 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 7.137087e-01 | 0.146 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.137087e-01 | 0.146 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 7.179585e-01 | 0.144 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 7.187903e-01 | 0.143 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 7.228068e-01 | 0.141 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 7.234095e-01 | 0.141 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.234095e-01 | 0.141 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 7.234095e-01 | 0.141 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 7.234095e-01 | 0.141 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 7.250914e-01 | 0.140 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 7.250914e-01 | 0.140 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 7.250914e-01 | 0.140 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 7.250914e-01 | 0.140 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 7.250914e-01 | 0.140 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 7.252787e-01 | 0.139 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 7.287631e-01 | 0.137 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 7.308989e-01 | 0.136 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 7.308989e-01 | 0.136 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 7.308989e-01 | 0.136 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 7.308989e-01 | 0.136 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 7.308989e-01 | 0.136 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 7.308989e-01 | 0.136 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 7.353026e-01 | 0.134 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 7.365935e-01 | 0.133 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 7.365935e-01 | 0.133 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 7.365935e-01 | 0.133 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 7.378778e-01 | 0.132 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 7.378778e-01 | 0.132 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 7.378778e-01 | 0.132 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 7.381874e-01 | 0.132 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 7.381874e-01 | 0.132 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 7.381874e-01 | 0.132 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 7.381874e-01 | 0.132 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 7.381874e-01 | 0.132 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 7.381874e-01 | 0.132 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 7.381874e-01 | 0.132 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 7.381874e-01 | 0.132 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 7.381874e-01 | 0.132 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 7.381874e-01 | 0.132 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 7.381874e-01 | 0.132 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 7.381874e-01 | 0.132 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 7.381874e-01 | 0.132 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 7.381874e-01 | 0.132 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 7.381874e-01 | 0.132 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 7.381874e-01 | 0.132 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 7.428475e-01 | 0.129 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 7.477400e-01 | 0.126 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 7.477400e-01 | 0.126 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 7.477923e-01 | 0.126 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 7.477923e-01 | 0.126 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 7.477923e-01 | 0.126 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.477923e-01 | 0.126 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 7.478971e-01 | 0.126 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 7.494887e-01 | 0.125 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 7.517394e-01 | 0.124 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 7.517394e-01 | 0.124 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 7.517394e-01 | 0.124 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 7.517394e-01 | 0.124 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 7.523017e-01 | 0.124 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 7.585330e-01 | 0.120 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 7.585330e-01 | 0.120 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 7.585330e-01 | 0.120 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 7.597734e-01 | 0.119 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 7.597734e-01 | 0.119 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 7.605744e-01 | 0.119 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 7.605744e-01 | 0.119 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 7.605744e-01 | 0.119 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.605744e-01 | 0.119 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 7.605744e-01 | 0.119 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 7.605744e-01 | 0.119 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 7.605744e-01 | 0.119 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 7.605744e-01 | 0.119 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 7.605744e-01 | 0.119 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 7.605744e-01 | 0.119 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 7.605744e-01 | 0.119 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 7.605744e-01 | 0.119 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 7.605744e-01 | 0.119 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 7.605744e-01 | 0.119 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 7.605744e-01 | 0.119 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 7.605744e-01 | 0.119 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 7.605744e-01 | 0.119 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 7.605744e-01 | 0.119 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 7.605744e-01 | 0.119 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 7.635325e-01 | 0.117 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 7.637657e-01 | 0.117 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.637657e-01 | 0.117 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.637657e-01 | 0.117 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 7.637657e-01 | 0.117 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 7.637657e-01 | 0.117 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 7.650057e-01 | 0.116 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.689752e-01 | 0.114 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 7.689752e-01 | 0.114 | 0 | 0 |
| Translation | R-HSA-72766 | 7.699521e-01 | 0.114 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 7.712109e-01 | 0.113 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 7.776893e-01 | 0.109 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 7.776893e-01 | 0.109 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 7.776893e-01 | 0.109 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 7.776893e-01 | 0.109 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 7.776893e-01 | 0.109 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 7.776893e-01 | 0.109 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 7.783815e-01 | 0.109 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 7.786658e-01 | 0.109 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 7.788529e-01 | 0.109 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.788529e-01 | 0.109 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 7.788529e-01 | 0.109 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 7.788529e-01 | 0.109 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 7.790701e-01 | 0.108 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 7.810483e-01 | 0.107 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 7.810483e-01 | 0.107 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 7.810483e-01 | 0.107 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 7.810483e-01 | 0.107 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 7.810483e-01 | 0.107 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 7.810483e-01 | 0.107 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 7.810483e-01 | 0.107 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 7.810483e-01 | 0.107 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 7.822162e-01 | 0.107 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 7.822162e-01 | 0.107 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 7.888216e-01 | 0.103 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 7.898042e-01 | 0.102 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 7.898042e-01 | 0.102 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 7.898042e-01 | 0.102 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 7.898042e-01 | 0.102 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 7.930886e-01 | 0.101 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 7.930886e-01 | 0.101 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 7.930886e-01 | 0.101 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 7.930886e-01 | 0.101 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 7.930886e-01 | 0.101 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 7.930886e-01 | 0.101 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 7.958320e-01 | 0.099 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 7.977552e-01 | 0.098 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 7.997726e-01 | 0.097 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 7.997726e-01 | 0.097 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 7.997726e-01 | 0.097 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 7.997726e-01 | 0.097 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 7.997726e-01 | 0.097 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 7.997726e-01 | 0.097 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 7.997726e-01 | 0.097 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 7.997726e-01 | 0.097 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 7.997726e-01 | 0.097 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 7.997726e-01 | 0.097 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 8.013649e-01 | 0.096 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 8.013649e-01 | 0.096 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 8.013649e-01 | 0.096 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 8.028063e-01 | 0.095 | 0 | 0 |
| Protein folding | R-HSA-391251 | 8.038013e-01 | 0.095 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 8.040529e-01 | 0.095 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 8.065080e-01 | 0.093 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 8.065080e-01 | 0.093 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.065080e-01 | 0.093 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 8.065080e-01 | 0.093 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.065080e-01 | 0.093 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 8.073141e-01 | 0.093 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.108050e-01 | 0.091 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 8.123871e-01 | 0.090 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 8.123871e-01 | 0.090 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 8.123871e-01 | 0.090 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 8.123871e-01 | 0.090 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.123871e-01 | 0.090 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 8.123871e-01 | 0.090 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 8.127150e-01 | 0.090 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 8.129957e-01 | 0.090 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 8.168966e-01 | 0.088 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 8.168966e-01 | 0.088 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 8.168966e-01 | 0.088 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.168966e-01 | 0.088 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 8.168966e-01 | 0.088 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 8.168966e-01 | 0.088 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.168966e-01 | 0.088 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 8.168966e-01 | 0.088 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 8.168966e-01 | 0.088 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 8.168966e-01 | 0.088 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 8.168966e-01 | 0.088 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 8.168966e-01 | 0.088 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 8.168966e-01 | 0.088 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 8.168966e-01 | 0.088 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 8.168966e-01 | 0.088 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 8.168966e-01 | 0.088 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 8.191467e-01 | 0.087 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 8.191467e-01 | 0.087 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 8.191467e-01 | 0.087 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.208355e-01 | 0.086 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 8.209803e-01 | 0.086 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 8.220709e-01 | 0.085 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 8.220709e-01 | 0.085 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 8.228868e-01 | 0.085 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 8.228868e-01 | 0.085 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 8.228868e-01 | 0.085 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 8.228868e-01 | 0.085 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 8.228868e-01 | 0.085 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 8.228868e-01 | 0.085 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 8.236829e-01 | 0.084 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 8.238390e-01 | 0.084 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 8.310373e-01 | 0.080 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 8.310399e-01 | 0.080 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 8.310399e-01 | 0.080 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 8.310399e-01 | 0.080 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.310399e-01 | 0.080 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.310399e-01 | 0.080 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 8.325571e-01 | 0.080 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 8.325571e-01 | 0.080 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.325571e-01 | 0.080 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.325571e-01 | 0.080 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 8.325571e-01 | 0.080 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.325571e-01 | 0.080 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 8.325571e-01 | 0.080 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.325571e-01 | 0.080 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 8.325571e-01 | 0.080 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 8.325571e-01 | 0.080 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 8.325571e-01 | 0.080 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.325571e-01 | 0.080 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 8.325571e-01 | 0.080 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 8.325571e-01 | 0.080 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 8.326099e-01 | 0.080 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 8.328806e-01 | 0.079 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 8.339285e-01 | 0.079 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 8.359055e-01 | 0.078 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 8.401065e-01 | 0.076 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 8.422227e-01 | 0.075 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 8.422227e-01 | 0.075 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 8.422227e-01 | 0.075 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 8.422227e-01 | 0.075 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 8.422227e-01 | 0.075 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.423853e-01 | 0.074 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 8.423853e-01 | 0.074 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 8.468790e-01 | 0.072 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 8.468790e-01 | 0.072 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 8.468790e-01 | 0.072 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 8.468790e-01 | 0.072 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 8.468790e-01 | 0.072 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 8.468790e-01 | 0.072 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 8.468790e-01 | 0.072 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 8.468790e-01 | 0.072 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.468790e-01 | 0.072 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 8.468790e-01 | 0.072 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 8.468790e-01 | 0.072 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.478416e-01 | 0.072 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 8.478416e-01 | 0.072 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 8.479194e-01 | 0.072 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 8.514180e-01 | 0.070 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 8.514180e-01 | 0.070 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 8.514180e-01 | 0.070 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 8.514576e-01 | 0.070 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 8.527297e-01 | 0.069 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 8.527297e-01 | 0.069 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 8.527297e-01 | 0.069 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 8.530405e-01 | 0.069 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.548381e-01 | 0.068 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 8.599767e-01 | 0.066 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 8.599767e-01 | 0.066 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 8.599767e-01 | 0.066 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 8.599767e-01 | 0.066 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 8.599767e-01 | 0.066 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 8.599767e-01 | 0.066 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 8.599767e-01 | 0.066 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 8.599767e-01 | 0.066 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 8.608148e-01 | 0.065 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 8.608148e-01 | 0.065 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 8.625944e-01 | 0.064 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 8.625944e-01 | 0.064 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 8.625944e-01 | 0.064 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 8.625944e-01 | 0.064 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 8.625944e-01 | 0.064 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 8.629743e-01 | 0.064 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 8.632110e-01 | 0.064 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.643517e-01 | 0.063 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 8.651141e-01 | 0.063 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 8.651141e-01 | 0.063 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 8.655640e-01 | 0.063 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.679866e-01 | 0.061 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 8.681360e-01 | 0.061 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 8.681360e-01 | 0.061 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 8.691327e-01 | 0.061 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 8.716434e-01 | 0.060 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 8.718500e-01 | 0.060 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 8.718500e-01 | 0.060 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 8.719547e-01 | 0.060 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 8.719547e-01 | 0.060 | 0 | 0 |
| PKA activation | R-HSA-163615 | 8.719547e-01 | 0.060 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 8.719547e-01 | 0.060 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 8.719547e-01 | 0.060 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 8.719547e-01 | 0.060 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 8.719547e-01 | 0.060 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 8.719547e-01 | 0.060 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 8.719547e-01 | 0.060 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 8.719547e-01 | 0.060 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 8.735540e-01 | 0.059 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.748401e-01 | 0.058 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 8.758556e-01 | 0.058 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 8.805283e-01 | 0.055 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 8.805283e-01 | 0.055 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 8.805283e-01 | 0.055 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 8.805283e-01 | 0.055 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.805283e-01 | 0.055 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 8.805283e-01 | 0.055 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 8.805283e-01 | 0.055 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 8.805283e-01 | 0.055 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 8.805283e-01 | 0.055 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 8.805283e-01 | 0.055 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 8.829088e-01 | 0.054 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 8.829088e-01 | 0.054 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 8.829088e-01 | 0.054 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 8.829088e-01 | 0.054 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 8.829088e-01 | 0.054 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 8.829088e-01 | 0.054 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 8.829088e-01 | 0.054 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 8.829088e-01 | 0.054 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 8.829088e-01 | 0.054 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 8.829088e-01 | 0.054 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 8.829088e-01 | 0.054 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 8.831715e-01 | 0.054 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 8.831715e-01 | 0.054 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 8.831715e-01 | 0.054 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 8.831715e-01 | 0.054 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 8.834636e-01 | 0.054 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 8.864123e-01 | 0.052 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 8.868205e-01 | 0.052 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 8.886604e-01 | 0.051 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 8.886604e-01 | 0.051 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 8.886604e-01 | 0.051 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 8.886604e-01 | 0.051 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 8.901005e-01 | 0.051 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 8.926175e-01 | 0.049 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 8.926175e-01 | 0.049 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 8.929263e-01 | 0.049 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 8.929263e-01 | 0.049 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 8.929263e-01 | 0.049 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 8.929263e-01 | 0.049 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 8.929263e-01 | 0.049 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 8.929263e-01 | 0.049 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 8.929263e-01 | 0.049 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 8.959214e-01 | 0.048 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.962763e-01 | 0.048 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 8.962763e-01 | 0.048 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 8.962763e-01 | 0.048 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 8.974103e-01 | 0.047 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 8.989057e-01 | 0.046 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.005064e-01 | 0.046 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 9.015707e-01 | 0.045 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.020874e-01 | 0.045 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 9.020874e-01 | 0.045 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 9.020874e-01 | 0.045 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 9.020874e-01 | 0.045 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.020874e-01 | 0.045 | 0 | 0 |
| Abacavir metabolism | R-HSA-2161541 | 9.020874e-01 | 0.045 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 9.020874e-01 | 0.045 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.020874e-01 | 0.045 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.028633e-01 | 0.044 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 9.034046e-01 | 0.044 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.034046e-01 | 0.044 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.034046e-01 | 0.044 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 9.046733e-01 | 0.044 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.060652e-01 | 0.043 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.087290e-01 | 0.042 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.094625e-01 | 0.041 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.097584e-01 | 0.041 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.100730e-01 | 0.041 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.100730e-01 | 0.041 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.104651e-01 | 0.041 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 9.104651e-01 | 0.041 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.104651e-01 | 0.041 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.104651e-01 | 0.041 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.104651e-01 | 0.041 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.104651e-01 | 0.041 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.104651e-01 | 0.041 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.104651e-01 | 0.041 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.163081e-01 | 0.038 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 9.163081e-01 | 0.038 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 9.181265e-01 | 0.037 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.181265e-01 | 0.037 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.181265e-01 | 0.037 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 9.181265e-01 | 0.037 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.181265e-01 | 0.037 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.181265e-01 | 0.037 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 9.181265e-01 | 0.037 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.195060e-01 | 0.036 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.195060e-01 | 0.036 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.214218e-01 | 0.036 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 9.215451e-01 | 0.035 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.221351e-01 | 0.035 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 9.221351e-01 | 0.035 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.221351e-01 | 0.035 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.221351e-01 | 0.035 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.228365e-01 | 0.035 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.244469e-01 | 0.034 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 9.251327e-01 | 0.034 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 9.251327e-01 | 0.034 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.251327e-01 | 0.034 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 9.251327e-01 | 0.034 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.251327e-01 | 0.034 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.251327e-01 | 0.034 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.251327e-01 | 0.034 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 9.251327e-01 | 0.034 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.259338e-01 | 0.033 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.275782e-01 | 0.033 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 9.285869e-01 | 0.032 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 9.291084e-01 | 0.032 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 9.301001e-01 | 0.031 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.301925e-01 | 0.031 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 9.307382e-01 | 0.031 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.309226e-01 | 0.031 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.315398e-01 | 0.031 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.315398e-01 | 0.031 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.315398e-01 | 0.031 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.326603e-01 | 0.030 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.326603e-01 | 0.030 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.326603e-01 | 0.030 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.326603e-01 | 0.030 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.326603e-01 | 0.030 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 9.326603e-01 | 0.030 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 9.326603e-01 | 0.030 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 9.331579e-01 | 0.030 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.335041e-01 | 0.030 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.336329e-01 | 0.030 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.338707e-01 | 0.030 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 9.344392e-01 | 0.029 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.350986e-01 | 0.029 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.367878e-01 | 0.028 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.373989e-01 | 0.028 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.376472e-01 | 0.028 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.378031e-01 | 0.028 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 9.399669e-01 | 0.027 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.407279e-01 | 0.027 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.415505e-01 | 0.026 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.415505e-01 | 0.026 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.415505e-01 | 0.026 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.418284e-01 | 0.026 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.418284e-01 | 0.026 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.427568e-01 | 0.026 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.427568e-01 | 0.026 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.427568e-01 | 0.026 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.427568e-01 | 0.026 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.427568e-01 | 0.026 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.427568e-01 | 0.026 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.427568e-01 | 0.026 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 9.427568e-01 | 0.026 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 9.438862e-01 | 0.025 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.452262e-01 | 0.024 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.459548e-01 | 0.024 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.459548e-01 | 0.024 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.459548e-01 | 0.024 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.459548e-01 | 0.024 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 9.459548e-01 | 0.024 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.459548e-01 | 0.024 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 9.461403e-01 | 0.024 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 9.465713e-01 | 0.024 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.469557e-01 | 0.024 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.476565e-01 | 0.023 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 9.476565e-01 | 0.023 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 9.476565e-01 | 0.023 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.476565e-01 | 0.023 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.476565e-01 | 0.023 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.476565e-01 | 0.023 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.479172e-01 | 0.023 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.479172e-01 | 0.023 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.486861e-01 | 0.023 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.489677e-01 | 0.023 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.491056e-01 | 0.023 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.498014e-01 | 0.022 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 9.501875e-01 | 0.022 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.519415e-01 | 0.021 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.521371e-01 | 0.021 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.533857e-01 | 0.021 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.533857e-01 | 0.021 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.550032e-01 | 0.020 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.561553e-01 | 0.019 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 9.561553e-01 | 0.019 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 9.562344e-01 | 0.019 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.562344e-01 | 0.019 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 9.562344e-01 | 0.019 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 9.562344e-01 | 0.019 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 9.562344e-01 | 0.019 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.565026e-01 | 0.019 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.567245e-01 | 0.019 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.578183e-01 | 0.019 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.581552e-01 | 0.019 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 9.584203e-01 | 0.018 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.588048e-01 | 0.018 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.599811e-01 | 0.018 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 9.599811e-01 | 0.018 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 9.599811e-01 | 0.018 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.615690e-01 | 0.017 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.626490e-01 | 0.017 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.627278e-01 | 0.016 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.634073e-01 | 0.016 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.634073e-01 | 0.016 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.634073e-01 | 0.016 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.634073e-01 | 0.016 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 9.634073e-01 | 0.016 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.637033e-01 | 0.016 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.655142e-01 | 0.015 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.657177e-01 | 0.015 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 9.657177e-01 | 0.015 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 9.657177e-01 | 0.015 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 9.657177e-01 | 0.015 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 9.663696e-01 | 0.015 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 9.665404e-01 | 0.015 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.666040e-01 | 0.015 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.679266e-01 | 0.014 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.679266e-01 | 0.014 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.679266e-01 | 0.014 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.698566e-01 | 0.013 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.702567e-01 | 0.013 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.708051e-01 | 0.013 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.711717e-01 | 0.013 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.715196e-01 | 0.013 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.718286e-01 | 0.012 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.720251e-01 | 0.012 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 9.720251e-01 | 0.012 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.720251e-01 | 0.012 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.720251e-01 | 0.012 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.724232e-01 | 0.012 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.736780e-01 | 0.012 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.744208e-01 | 0.011 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.744208e-01 | 0.011 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.744208e-01 | 0.011 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.744208e-01 | 0.011 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.765528e-01 | 0.010 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.766114e-01 | 0.010 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.771968e-01 | 0.010 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 9.780465e-01 | 0.010 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.780465e-01 | 0.010 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 9.784210e-01 | 0.009 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 9.784210e-01 | 0.009 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 9.785077e-01 | 0.009 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.785589e-01 | 0.009 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.786145e-01 | 0.009 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.786145e-01 | 0.009 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.786145e-01 | 0.009 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.786145e-01 | 0.009 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 9.794240e-01 | 0.009 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.796611e-01 | 0.009 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.804462e-01 | 0.009 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.804462e-01 | 0.009 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.813198e-01 | 0.008 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.813198e-01 | 0.008 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 9.817801e-01 | 0.008 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 9.817801e-01 | 0.008 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.821210e-01 | 0.008 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.821210e-01 | 0.008 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.825519e-01 | 0.008 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.825519e-01 | 0.008 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.825695e-01 | 0.008 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.825695e-01 | 0.008 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.825695e-01 | 0.008 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.829414e-01 | 0.007 | 0 | 0 |
| Diseases associated with N-glycosylation of proteins | R-HSA-3781860 | 9.836526e-01 | 0.007 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.837391e-01 | 0.007 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.838435e-01 | 0.007 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.839478e-01 | 0.007 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 9.840686e-01 | 0.007 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 9.840686e-01 | 0.007 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 9.850419e-01 | 0.007 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.850530e-01 | 0.007 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.859425e-01 | 0.006 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.859425e-01 | 0.006 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.863335e-01 | 0.006 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.870858e-01 | 0.006 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.875044e-01 | 0.005 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.875044e-01 | 0.005 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.877081e-01 | 0.005 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.890941e-01 | 0.005 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.891517e-01 | 0.005 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.895540e-01 | 0.005 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 9.896166e-01 | 0.005 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 9.896823e-01 | 0.005 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 9.900552e-01 | 0.004 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.901886e-01 | 0.004 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 9.904491e-01 | 0.004 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 9.904491e-01 | 0.004 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.906108e-01 | 0.004 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.906108e-01 | 0.004 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.907367e-01 | 0.004 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.908285e-01 | 0.004 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.911217e-01 | 0.004 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.911217e-01 | 0.004 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.912676e-01 | 0.004 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.914354e-01 | 0.004 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 9.917119e-01 | 0.004 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.920178e-01 | 0.003 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 9.925756e-01 | 0.003 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 9.925756e-01 | 0.003 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 9.925756e-01 | 0.003 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.930446e-01 | 0.003 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.931363e-01 | 0.003 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.931363e-01 | 0.003 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.931363e-01 | 0.003 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.933259e-01 | 0.003 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 9.933259e-01 | 0.003 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.933259e-01 | 0.003 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 9.936555e-01 | 0.003 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.938980e-01 | 0.003 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.943913e-01 | 0.002 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.943913e-01 | 0.002 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.944211e-01 | 0.002 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.944567e-01 | 0.002 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.947030e-01 | 0.002 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.947030e-01 | 0.002 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.947030e-01 | 0.002 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.947826e-01 | 0.002 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.947973e-01 | 0.002 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 9.948011e-01 | 0.002 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.948993e-01 | 0.002 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.949928e-01 | 0.002 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.950662e-01 | 0.002 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.951474e-01 | 0.002 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.954845e-01 | 0.002 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.957364e-01 | 0.002 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.963540e-01 | 0.002 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.964363e-01 | 0.002 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.968975e-01 | 0.001 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.970213e-01 | 0.001 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.974042e-01 | 0.001 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.976591e-01 | 0.001 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.979191e-01 | 0.001 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.982608e-01 | 0.001 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.982670e-01 | 0.001 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.982711e-01 | 0.001 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.985857e-01 | 0.001 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.986065e-01 | 0.001 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.986065e-01 | 0.001 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.987852e-01 | 0.001 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.988669e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.988894e-01 | 0.000 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.990719e-01 | 0.000 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.990842e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.991515e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.991814e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.992096e-01 | 0.000 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.992415e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.992714e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.992909e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.992909e-01 | 0.000 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 9.993190e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.993809e-01 | 0.000 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.993836e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.994075e-01 | 0.000 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 9.994294e-01 | 0.000 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.995266e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.995885e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.996994e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.997230e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.997359e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.997684e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.998192e-01 | 0.000 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.998216e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.998450e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.998450e-01 | 0.000 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.998824e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.998913e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999179e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999273e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999314e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999476e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.999559e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.999610e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999737e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.999761e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999822e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999844e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999864e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999875e-01 | 0.000 | 0 | 0 |
| Initial triggering of complement | R-HSA-166663 | 9.999886e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999889e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.999905e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999921e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.999924e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999925e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999941e-01 | 0.000 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.999945e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999949e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999961e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999961e-01 | 0.000 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.999966e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999967e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999975e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999975e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999978e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999981e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999981e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999986e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999989e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999990e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999993e-01 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 9.999995e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999996e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999999e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999999e-01 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999999e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |